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Abstract 
Background: Research in infectious diseases underwent a revolution with the uprising of 
Omics approaches, including, but not limited to, genomics, metagenomics and 
metatranscriptomics. In fact, there are several examples where Omics approaches 
showed their potential to tackle different challenges related to the versatile nature of 
infectious diseases by promoting “studies of one” to “system-wide studies”. In the frame 
of this PhD programme, we focused on the development and validation of Omics 
approaches and bioinformatics workflow aiming at tackling mainly diagnostics but also to 
some extents the treatment of infectious diseases. The four applications presented in this 
thesis had following specific objectives; (i) to develop and validate a bioinformatics 
approach aiming at selecting high quality markers among a large amount of complete 
genomic sequences; (ii) to characterise the viral metagenome of a plant to determine 
aetiology of a disease that could not be identified and/or fully characterised with other 
tools; (iii) to assess the potential of metagenomics in the field of personalised medicine 
and compare its diagnostics accuracy with validated diagnostics tools; and (iv) to make a 
system-wide survey of microbial populations and estimate its potential to cause harm to 
humans. 
Methods: Methodology was specific for each application but as a general rule, we only 
used published bioinformatics tools that have been used and validated in other studies. 
This includes, but is not limited to, the BLAST algorithm for the comparison of sequences 
to various databases and the MIRA assembler to assemble the metagenomics datasets 
obtained within the different projects. 
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Results: For clarity, the results are summarised by project, corresponding to the different 
applications investigated during this PhD. 
Project (i): The developed bioinformatics workflow allowed the selection of highly 
conserved and specific molecular markers among various viral species with inputs of up 
to several hundred complete genomic sequences. The quality of the selected markers 
was successfully validated using several types of molecular assays including real-time 
PCR, LAMP and Sanger sequencing. 
Project (ii): We were able to find the aetiology of a grapevine plant presenting leafroll 
symptoms. A new virus, named Grapevine Leafroll-associated virus 4 Ob, with a thirteen 
kilobases genome was found in the viral metagenome. Other viruses that were co-
identified in the virome were known to be asymptomatic viruses for grapevine, and with 
the help of additional serological experiences, we were able to confirm that this GLRaV-
4 Ob was the causative agent of the Leafroll symptoms. 
Project (iii): The gut pathobiomes from four patients presenting persistent digestive 
disorders were fully characterised using a metagenomics approach. Comparison of 
validated diagnostics tools with this approach showed that the diagnostics rate was in 
favour of the latter for the detection of bacterial and helminths pathogens and in favour of 
the validated tools for the detection of viruses and protozoa. Using the same datasets, 
but compared to a different database, we were also able to screen the stool samples for 
antimicrobial resistance genes and retrieve potential resistance genes that might interfere 
with the treatment of these patients.   
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Project (iv): In this project, a system-wide assessment of the microbial communities of the 
wastewater treatment system was done using a metagenomics approach. We were able 
to demonstrate how closely the genetic diversity of Escherichia coli and the overall 
genetic diversity were linked in this environment. We were also able to map the repartition 
of different pathogenic classes, including bacteria, helminths, intestinal protozoa and 
viruses as well as to show if and how human waterborne pathogens spread throughout 
this ecosystem.   
Conclusion: Omics offer new strategies of how challenges, mainly related to the vast 
diversity within the research area of infectious diseases, can be tackled. Meta-analyses, 
like metagenomics or metatranscriptomics are the applications that benefited most from 
the use of Next-Generation Sequencing technologies, and they now allow system-wide 
studies where previous studies were only focusing on one parameter (one microbe or one 
specific gene for instance). However, these Omics approaches have their limitations, 
mainly due to the bioinformatics challenges they give rise to. As a general conclusion, it 
is foreseeable that, because of the increased amount of results they generate, Omics 
approaches, once matured, will be more widely used and will replace standard 
approaches in the field of infectious diseases. 
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Résumé 
Contexte : La recherche en maladies infectieuses a subi une révolution avec l’avènement 
des approches Omiques, incluant mais n’étant pas limitées à, la génomique, la 
métagénomique et la métatranscriptomique. Les approches Omiques ont été utilisées 
pour aborder la diversité intrinsèque des maladies infectieuses et ont permis de passer 
des études limitées à un paramètre aux études de systèmes complets. Dans le cadre de 
ce doctorat, nous nous sommes concentrés sur le développement et la validation de ces 
approches Omiques ainsi que des pipelines d’analyse bio-informatique dans le diagnostic 
ainsi que certains aspects du traitement des maladies infectieuses. Le but des quatre 
applications testées durant cette thèse étaient ; (i) de développer et valider une approche 
de bio-informatique capable d’analyser un grand nombre de séquences dans le but de 
sélectionner des marqueurs moléculaires et de les valider à l’aide de différents tests 
moléculaires; (ii) de caractériser le métagenome viral d’une plante pour déterminer 
l’origine d’une maladie; (iii) d’analyser le potentiel de la métagénomique dans le domaine 
de la médecine personnalisée ainsi que de valider son potentiel de diagnostic; et (iv) de 
réaliser l’analyser microbienne complète d’un environnement complexe et d’estimer le 
risque qu’il présente pour la santé humaine. 
Méthodologie : Les méthodes utilisées sont spécifiques pour chaque application mais en 
règle générale, seuls des outils de bio-informatique reconnus et publiés ont été utilisés. 
Ces logiciels incluent, mais ne sont pas limités, à l’algorithme de BLAST pour la 
comparaison de séquences à différentes bases de données ou l’assembleur MIRA qui a 
été utilisé pour assembler les données de métagénomique. 
Résultats : Pour des raisons de clarté, les résultats ont été regroupés par projet. 
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Projet (i) : Le pipeline de bio-informatique a permis de sélectionner des marqueurs 
moléculaires hautement conservés et spécifiques pour différents pathogènes viraux 
parmi un grand nombre de séquences génomiques. La qualité de ces marqueurs a été 
validée en utilisant différents types de tests moléculaires. 
Projet (ii) : Il a été possible de déterminer l’organisme responsable des symptômes 
observables sur un plant de vigne. Un nouveau virus, nommé « Virus de l’enroulement 
de la vigne 4 Ob » ou « GLRaV-4 Ob », possédant un génome d’environ 13 kilobases a 
été détecté dans le métagenome viral. Du fait que les autres virus détectés dans le virome 
sont connus pour ne pas causer de symptômes dans la vigne et à l’aide d’expériences 
supplémentaires, il a été possible de confirmer que le virus GLRaV-4 Ob est l’agent 
pathogène responsable des symptômes observés. 
Projet (iii) : En utilisant une approche de métagénomique, il a été possible de caractériser 
le pathobiome intestinal chez des patients présentant des troubles gastro-intestinaux 
persistants. La comparaison du diagnostic est en faveur de l’approche métagénomique 
pour les pathogènes bactériens ainsi que les helminthes mais les outils de diagnostic 
standard permettent une meilleure identification des pathogènes viraux et des 
protozoaires. 
Projet (iv) : Ce projet a permis, avec l’utilisation d’une approche de métagénomique, de 
caractériser les communautés microbiennes du réseau de traitement des eaux usées de 
la ville de Kampala, Ouganda. Il a été possible de démontrer que la diversité génétique 
d’Escherichia coli est intimement liée à la diversité génétique bactérienne générale dans 
cet environnement. Il a également été possible de répertorier géographiquement les 
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différentes classes de pathogènes ainsi que les principaux pathogènes transmis aux 
humains par contact direct ou ingestion de l’eau. 
Conclusion : Les approches Omiques ont permis le développement de nouvelles 
stratégies permettant l’analyse de la diversité intrinsèque aux maladies infectieuses. Les 
méta-analyses, telle que la métagénomique ou la métatranscriptomique sont les 
applications qui ont le plus bénéficié de l’utilisation du séquençage de nouvelle génération 
et elles permettent maintenant la caractérisation complète de différents systèmes. 
Pourtant, ces approches Omiques ont leurs limitations qui sont principalement liées aux 
analyses bio-informatiques. En conclusion, il est plausible que ces approches Omiques, 
une fois optimisées, seront de plus en plus utilisées jusqu’à remplacer les approches 
actuellement utilisées dans le domaine des maladies infectieuses. 
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Chapter I. Introduction 
1. Infectious diseases 
a. Definition 
Infectious diseases, also known as transmissible diseases or communicable diseases, 
are illnesses resulting from the infection of a host by a pathogenic microorganism. The 
spectrum of pathogenic microorganisms is extremely wide, resulting in the fact that any 
living organism, including plants, animals, as well as microorganisms, can become 
infected and hence, a symptomatic host. An overview of the principal areas in the field of 
infectious diseases research (Anderson et al 1992) is shown in Figure 1.  
 
 
Figure 1. Areas of infectious diseases research. This figure represents the processes 
involved in infection, from the initial infection step to the final treatment step. Research 
focuses are similar for infectious diseases occurring in human, veterinarian and plant 
health. 
b. Pathogens 
The etymology of the word “pathogen” has a negative connotation, literally translating 
from Greek to “suffering producer” (pathos and –genes). A pathogen is a microorganism 
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which has the potential to infect a host organism and cause the symptomatic expression 
of a disease. Pathogens are, however, like any other living organism, only trying to survive 
and replicate (Alberts et al 2002). The strategy adopted by pathogens, as shown in Figure 
2, is quite effective since it consists in using the hosts’ energy or molecular machinery to 
achieve its own survival (Hilleman 2004, Hingley-Wilson et al 2003).  
 
Figure 2. Generic lifecycle of a pathogen. Because of the broad diversity of pathogens, 
there is a wide range of variations and specificities in the lifecycles of each pathogen. 
These variations occur because pathogens need to adapt, among other things, to their 
respective reservoirs, environments, intermediate hosts, and final hosts. 
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c. Diversity of pathogens 
From phylogenetic and phenotypic point-of-views, microbial pathogens are extremely 
diverse. In this brief overview, microbial pathogens have been sorted into five main 
classes, namely; (i) helminth parasites, (ii) protozoan parasites; (iii) bacterial pathogens, 
(iv) viral pathogens, and (v) fungal pathogens.  
Helminths, also commonly known as parasitic worms, are large multicellular 
organisms which can be classified into three main groups, namely Nemathelminths, 
Cestodes and Trematodes as shown in Figure 3. 
 
Source : http://parasite.org.au/para-site/contents/helminth-intoduction.html 
Figure 3. Main groups of helminth parasites. These includes nematodes and flatworms, 
the second being divided into two subgroups, tapeworms and flukes.  
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Due to their higher complexity, genomes of helminth parasites have not yet been 
extensively sequenced, but estimates indicate that their genome sizes span between 50 
and 500 Mb (Hotez et al 2008). However, their health impact is so important, with 
estimates of over 1 billion infected people, that genomics projects have become more 
and more common (Brindley et al 2009, Hotez et al 2008, Lustigman et al 2012) and high 
quality assembled genomes are expected to become available in the near future for a 
wider range of helminth species. In September 2015, 2’752’593 nucleotide sequences 
were available for flatworms as well as 1’955’922 nematodes sequences in the National 
Centre for Biotechnology Information sequence database, Genbank, which is the main 
sequence repository publicly available (Benson et al 2013). 
Protozoa are unicellular eukaryotes which can be divided into four subgroups, 
based on their locomotion strategies, namely, (i) amoebae, (ii) flagellates, (iii) ciliates, and 
(iv) sporozoa as shown in Figure 4. 
 
Source : http://parasite.org.au/para-site/contents/protozoa-intoduction.html 
Figure 4. Subgroups of the protozoa embranchment. Protozoa are sub-divided in groups 
based on their locomotion strategies. 
 23 
 
The World Health Organisation (http://www.who.int/)  has identified ten major, yet 
neglected, infectious diseases (African trypanosomiasis, Chagas disease, dengue fever, 
lymphatic filariasis, leishmaniosis, leprosy, malaria, onchocerciasis, schistosomiasis, and 
tuberculosis) that are currently being intensively studied to provide control measures or 
even eradication measures for the causative agents. Four of them, namely, African 
trypanosomiasis, Chagas disease, leishmaniosis and malaria are caused by protozoan 
parasites and account for over 1.3 million deaths annually, possibly even more (Ersfeld 
2003). So far, approximately 40’000 protozoa species have been described (Antonello 
2007). The Welcome Trust Sanger Institute provides information on current and past 
protozoan sequencing projects and the genome sizes of completed projects span from 
approximately 8,3 Mb for Theileria annulata to over 62 Mb for Neospora caninum. To 
date, 84’958 protozoa nucleotide sequences are available in the Genbank database. 
Bacteria are present in most of Earth’s habitats and are found in various shapes 
including spheres, spirals and rods. Their size is typically between 0.5 and 5 µm as shown 
in Figure 5 with some species, like Thiomargarita namibiensis reaching up to 0.75 mm 
(Schulz and Jørgensen 2001), making them visible to the naked eye. 
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Source : http://www.ppdictionary.com/ 
Figure 5. Bacterial shapes and order of size. Left panel shows spherical bacteria, middle 
panel shows rod-shaped bacteria and right panel a spiral-shaped bacterium.  
There are currently 15’974 bacterial taxa (Parte 2014) and bacterial genomes range from 
approximately 130 Kbp (McCutcheon and Moran 2012) to over 14 Mbp for Sorangium 
cellulosum (Han et al 2013). With 20’401’838 nucleotide sequences in the Genbank 
database, this is the most extensively sequenced of the five pathogenic classes 
presented here. 
Viruses are the most important biological entities with an estimated 1031 viruses 
on Earth (Breitbart and Rohwer 2005, Edwards and Rohwer 2005). They are found in 
every type of ecosystem on this planet and they are present in a variety of shapes and 
sizes, as shown in Figure 6. 
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Source : http://academic.pgcc.edu/~kroberts/Lecture/Chapter%2013/shape.html 
Figure 6. Various morphologies of viral particles. Panel A. Helical-shaped virus. Panel B. 
Aggregates of icosahedral shaped viruses. Panels C and D. Viral particles with random, 
more complex shapes.  
Viruses can infect any other living organism (Koonin et al 2006) and require the 
hosts’ cellular machinery to replicate. Viral genomes can be composed of DNA or RNA, 
be double-stranded or single stranded, and finally, segmented or not segmented. The 
International Committee on Taxonomy of Viruses, which is the reference organisation for 
the taxonomy of viruses, identified a list of 3’186 viral species in its annual report of 2014 
(http://www.ictvonline.org/virusTaxInfo.asp). These species were classified in 505 genera 
distributed into 104 Families. 2’016’112 viral nucleotide sequences were available in the 
Genbank database as of September 2015.  
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Fungi include both unicellular and multicellular eukaryotic microorganisms. They are 
sorted in the fungi group mainly due to the fact that, unlike plants, bacteria and protozoa, 
their cell walls produce chitin. There is an estimated 1’500’000 fungal species on Earth 
but only 300 have been described as pathogenic for humans (Garcia-Solache and 
Casadevall 2010, Hawksworth 2001). With 5’452’827 available on Genbank, Fungal 
microorganisms are the second most represented pathogenic class in the Genbank 
database. 
d. Pathogenic types 
Pathogenic microorganisms can be either primary pathogens or opportunistic pathogens. 
Primary pathogens are microorganisms that cause symptoms when they cross the hosts’ 
defensive barriers. A good example of primary pathogens are the three main parasitic 
species causing schistosomiasis, Schistosoma mansoni, S. japonicum and S. 
haematobium. The natural reservoirs of schistosomes are various freshwater snail 
species, namely Biomphalaria spp. for S. mansoni, Oncomelania spp. for S. japonicum 
and Bulinus spp. for S. haematobium. Human infections only occur through direct contact 
with water which has been contaminated with cercariae (= infectious life stage of the 
parasite) released by the host snails (Jordan and Webbe 1969, Sturrock et al 1993).  
Opportunistic pathogens are microorganisms which are normally found in the 
environment or in association with various parts of the body. While they usually don’t 
cause disease in healthy individuals, they are able to cause illness in patients with certain 
specific conditions such as immunocompromised individuals. Many examples of 
opportunistic pathogens can be found directly in the human gut microbiome, with the most 
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important being probably Escherichia coli (non-pathogenic strains). In healthy patients, 
E. coli are associated with the degradation of organic matter in the gut and is also closely 
related to other normal functions of the gastrointestinal tract (Chang et al 2004, Isolauri 
et al 2001, Kruis et al 2004). In immunocompromised patients, however, certain E. coli 
strains can cross the gastrointestinal barrier and migrate to the bladder or urinary tract 
and therefore cause various severe symptoms (Kaper et al 2004, Manges et al 2001). 
Another example of opportunistic pathogen is the bacteria Acinetobacter baumanii, often 
associated with nosocomial infections. While it is an almost ubiquitous bacteria in hospital 
settings, it usually only colonizes the human body without causing any symptoms, but, 
might give rise to pulmonary infection, septicaemia and wound infection in weakened 
patients (Camp and Tatum 2010, Fournier et al 2006). 
e. Natural reservoirs of pathogens 
A variety of environments can serve as reservoirs for pathogens. This includes both living 
organisms as well as environmental niches. Recent examples of diseases transmitted to 
humans from their natural reservoirs include bats, acting as the natural reservoir for 
various Ebola outbreaks (Baize et al 2014, Leroy et al 2005) or the Middle East respiratory 
syndrome coronavirus found in dromedary camels (Azhar et al 2014, Raj et al 2014) and 
infecting humans by direct contact. On the plant side, examples of reservoirs include 
xylem feeding leafhoppers for the bacteria Xylella fastidiosa, an important pathogen with 
a major economic impact (Blua et al 1999, Hopkins 1989, Mizell et al 2003). Moreover, 
these same reservoirs can also often harbour multiple pathogens at the same time, hence 
vectoring multiple human, veterinary or plant pathogens. Bats, for instance, are believed 
to be the natural reservoir of approximately 20 % of all mammalian-infecting viruses and 
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is considered as one of the most important reservoir for emerging and re-emerging human 
diseases (Calisher et al 2006, Daszak et al 2000). Similarly, there is intra-reservoir 
pathogen diversity in camels, which, in addition to MERS-CoV were also shown to 
transmit the Camelpox virus to humans by direct contact (Bera et al 2011).  
f. Cumulative burden of coinfections 
In parasitology, coinfection is the simultaneous infection of a host by several parasites. 
Data about coinfections in humans is lacking but it is thought to be extremely common 
(Cox 2001, Pullan and Brooker 2008), sometimes being more prevalent than single 
infections in specific settings (Petney and Andrews 1998). In virology and bacteriology, 
the term coinfection applies for cells infected with two or more viral or bacterial species. 
Several examples involve bacteria and viruses in coinfection events causing serious 
outcomes on human health. These include infections of patients with both the human 
immunodeficiency virus and Mycobacterium tuberculosis, responsible for acquired 
immune deficiency syndrome and tuberculosis, respectively (Pawlowski et al 2012). This 
particular case poses serious public health challenges, due mainly to multidrug-resistant 
strains of Mycobacterium tuberculosis which strive in immunocompromised patients and 
are now widely spread (Streicher et al 2015, Zignol et al 2012). Another bacterial/viral 
coinfection synergy example are patients infected with both Influenza virus and 
pneumonia-causing bacteria. A recent review showed that more than 65’000 deaths per 
year are attributable to influenza and pneumonia occurring together in the United States 
(Chertow and Memoli 2013). A final example of coinfection causing aggravated health 
outcomes is infection with the HIV-Viral hepatitis complex (HBV, HCV, HDV), that is 
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reported to cause sever liver disease and jeopardise the effectiveness of HIV treatment 
(Alter 2006, Casey et al 1996, Kiesslich et al 2009). 
g. Pathogen genomics and associated challenges 
Genomics is, with the advent of next-generation sequencing technologies and future 
sequencing technologies, one of the scientific areas that produces the highest amounts 
of data, with an expected exabase of sequence produced in the next decade (Stephens 
et al 2015). This consequent amount of sequencing data will pertain all types of living 
organisms, but will be mainly focused on human genomes with several hundred 
thousands sequenced genomes along with a few millions of sequenced microbes, for 
which the genome size is, however, smaller than the human genome (Stephens et al 
2015). This large amount of information is two-sided, as, on one hand, it will allow 
researchers to gain new and deeper insights into multiple areas of infectious diseases, 
including, but not limited to, epidemiology, diagnostics, and pathogenesis of infectious 
diseases as well as species-species and species-host interactions (Bessen et al 2014, 
Depledge et al 2014, Feero et al 2011, Rappuoli 2004). On the other hand, however, this 
amount of data also raises questions surrounding data analysis, data safety and 
bioinformatics approaches, which are not developing at the same pace as sequencing 
technologies (Fernald et al 2011, Pop and Salzberg 2008, Stephens et al 2015). 
h. Pathogen identification and genetic traits 
In addition to increase accuracy for pathogen discovery and diagnostics, the amount of 
information accompanying the genomics era also enabled the creation of extensive gene 
databases pertaining different phenotypic characters pathogens. These aspects include 
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mobile genetic elements such as bacterial phages, plasmids, virulence factors and 
antimicrobial resistance genes (Chen et al 2005, Leplae et al 2004, McArthur et al 2013, 
Zhou et al 2007, Zuo et al 2007). The latter is a good example of bioinformatics challenges 
that need to be addressed before these databases make their way to the clinical setting. 
In this case, specific challenges exist, mainly due to the diversity of resistance 
mechanisms adopted by bacterial pathogens. These mechanisms can be either due to 
acquired plasmids carrying resistance genes, point mutations in the antibiotics targets or 
modified expression of genes coding for efflux pumps (Mah and O'Toole 2001, Martínez 
2008, Stewart and Costerton 2001). Therefore, the related bioinformatics challenges in 
this specific context are due to; (i) the fact that plasmid-driven resistance is difficult to 
attribute to one organism as plasmids might be exchanged between bacterial species; (ii) 
the fact that point mutations need a deep sequencing coverage to rule out sequencing 
errors and confirm quality of assembled sequences; and (iii) that bioinformatics analyses 
involving metagenomics or metatranscriptomics approaches need to take quantitative 
information into account when screening for efflux-based resistance (Schneeberger et al 
2015). 
2. Challenges in infectious diseases research 
The aspects of pathogens mentioned in the previous subchapter are all recurrent 
challenges where much remains to be researched. Their respective impact on the field of 
infectious diseases is shown in Figure 7. The focus of this thesis is located mainly 
between diagnostics and treatment as the two main objectives were i) to assess the 
potential of omics in the area of pathogen diagnostics and ii) to use omics techniques in 
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the area of patient treatment to providing advanced molecular characterization of the 
pathogen. 
 
Figure 7. Pathogens traits and associated bottlenecks in infectious diseases research. 
Different dash types of the connectors indicate different impacts, the solid line indicates 
a stronger impact than the dashed line. 
a. Current diagnostic approaches 
Current diagnostic approaches in the field of infectious diseases rely mainly on four 
strategies, namely; (i) culture-based diagnostic approaches; (ii) microscopy diagnostics; 
(iii) immunological diagnostics; and (iv) molecular diagnostic approaches. This 
subchapter summarises the different tools available and their specificities. 
b. Culture-based diagnostics 
Culture-based diagnostics is mainly used in bacteriology (Fischbach and Dunning 2009, 
Washington 1996) and virology (Leland and Ginocchio 2007) and to a lesser extent in 
 32 
 
parasitology (Visvesvara and Garcia 2002). For bacteria, the diagnostic is based on the 
use of selective mediums that allow the growth of bacterial species with specific 
biochemical properties. Bacterial pathogens are identified based on these phenotypes. 
Diagnosis of viral diseases relies on the isolation of viruses in adequate cell cultures. 
Parasite diagnosis on culture is more complex, since it may require different environments 
for each life stage. 
Pros Cons 
Standardised 
protocols 
Not available for all pathogens 
Accurate 
identification 
Low throughput (one culture = one identification) 
No information about the intra-species genetic diversity 
May require long incubation time for some microbes 
Infectious material, requires specific facilities 
Table 1. Pros and cons of culture-based diagnostics. 
c. Microscopy 
Microscopy is the most common method used both for the detection of microorganisms 
directly in clinical specimens and for the characterisation of organisms grown on culture 
media. Microscopy is defined as the use of a microscope to visually enlarge objects too 
small to be visualised with the naked eye so that their phenotypes can become 
observable. There are four main classes of microscopes used in diagnostic microbiology, 
namely; (i) bright-field microscopes used to identify bacteria, fungi, and parasites; (ii) 
fluorescence microscopes which can be used for any of the five pathogen classes; (iii) 
dark-field microscopes used for the identification of bacteria; and (iv) electron 
microscopes mainly used to diagnose parasites and viruses. 
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Pros Cons 
Optical microscopy is fast and 
inexpensive 
Other microscope types require expensive equipment 
Accurate diagnostics requires an experienced operator 
Complex samples are difficult to analyse 
Accurate identification at low taxonomic level is difficult 
Table 2. Pros and cons of microscopy-based diagnostics (Mabey et al 2004). 
d. Immunoassays 
Immunoassays are protein based assays that allow the detection and/or quantification of 
an antibody/antigen reaction during an infection event. Antibodies are used as probes to 
detect a specific antigen and are linked to a reactive molecule, be it a radiolabel, a 
fluorescent label or a colour-forming enzyme. Immunoassays are available for a wide 
range of microorganisms for each pathogenic class. They are also often available in the 
format of rapid-diagnostics tests, making them an excellent tool for point-of-care 
diagnostics. 
Pros Cons 
Fast and relatively inexpensive 
Specific to one or a group of closely related 
microorganisms 
Highly specific Relies on the immune response of the host 
Ease-of-use (e. G. RDTs) Identification at low taxonomic level can be difficult 
Table 3. Pros and cons of immunodiagnostics (Jacobson 1998). 
e. Molecular-based assays 
Molecular diagnostics is based on the amplification of a specific genomic region of a 
pathogen, also known as diagnostic sequence. Since genetic information is highly specific 
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to each microbial species, these tests are usually very accurate and have a high 
discriminative power. They can be used for the diagnostics of all pathogen classes, 
provided nucleotide sequences are available to select an amplification target. These 
assays include Polymerase Chain Reaction, real-time PCR, Loop-mediated isothermal 
amplification, DNA microarrays, Sanger sequencing and a number of other variations of 
PCR. 
Pros Cons 
Highly discriminative and specific Assay design requires the organism to be sequenced 
Identification at any taxonomic 
level 
 Not possible if intra-taxon genetic diversity is too high 
Low per reaction price  but expensive equipment 
Standardised protocols Quality of the assay depends on input sequences used for 
the selection of the amplification target Allows phylogenetic studies 
Table 4. Pros and cons of molecular-based diagnostics. (Mancini et al 2010, Yang and 
Rothman 2004) 
3. Next-generation sequencing and implication in pathogen diagnostics 
Current diagnostics approaches, except for the specific case of diagnostics microarrays, 
present a shared limitation since they all follow the “one assay = one organism” rule. 
While this is not a problem for studies focusing specifically on e.g. the epidemiology of 
one microorganism, it becomes problematic to understand system-wide dynamics, e.g. 
to study all species-host or species-species interactions, since hosts are rarely colonized 
by a single microorganism. In fact, there are several examples where NGS showed its 
potential to tackle the different challenges related to the versatile nature of infectious 
diseases by providing a tool allowing this research area to upgrade from “studies of one” 
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to “system-wide studies”, or molecular meta-analyses. These new studies include, but 
are not limited to, complete characterisation of microbial populations, or microbiomes as 
well as system-wide characterisation of additional molecular features relevant to gain 
further insights into infectious diseases. 
a. Evolution and impact of NGS technologies 
Next-generation sequencing started a revolution in early 2000 in the field of genomics 
and genome-wide studies with the introduction of the 454-pyrosequencing technology 
(Mardis 2008, Shendure and Ji 2008, Williams et al 2006). The introduction of this 
technological advance, with the 454 FLX instrument from Roche (Dressman et al 2003, 
Margulies et al 2005), allowed the multiplication of the output of Sanger sequencing by a 
factor of 10000, from a thousand base pair to over 100 Mb produced in a single 
sequencing run (Droege and Hill 2008). As a consequence, sequence repositories, such 
as Genbank, have increased dramatically in size and management and storage of this 
massive data amount is currently one of the major challenge (Mohammed et al 2012, 
Stephens et al 2015), along with the flourishing nebula of non-standardised bioinformatics 
tools and pipelines that makes it difficult for biologists without informatics knowledge to 
keep an overview (Fernald et al 2011, Moore et al 2010). The most notable example of 
benefits NGS has brought to the field of genomics is the significant decrease in the price 
of sequencing human genomes, which was roughly around 70’000’000 USD in the pre-
genomics era, 1’000’000 USD at the beginning of the genomics era and is now roughly 
around 1’000 USD (Metzker 2010, Shendure and Ji 2008, van Dijk et al 2014), making 
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the concept of personalised medicine come even closer to reality (Feero and Guttmacher 
2014, Ingelman‐Sundberg 2015, Shukla et al 2015). 
b. NGS technologies in 2015 
There are currently four main NGS technologies used on the market, namely, (i) 
pyrosequencing (454 sequencing); (ii) semiconductor-based sequencing (Ion Torrent); 
(iii) sequencing-by-synthesis (Illumina); and (iv) first generation single molecule 
sequencing (Pacific Biosciences). Technical characteristics of the different sequencing 
platforms are briefly summarised in Figure 8. 
 
Figure 8. Technical characteristics of 
next-generation sequencing platforms in 
2015. Panel A. Maximum read-length at 
the early commercial stages of the 
technologies and current read-length. 
Panel B. Sequencing output at the 
commercialisation of the technology and 
current sequencing output. Panel C. 
Comparison of runtime with early 
protocols and current protocols. 
(Shendure and Ji 2008, van Dijk et al 
2014).
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Next-generation sequencing has now been applied in a variety of studies (Ekblom 
and Galindo 2011, Lee et al 2013, McCormack et al 2013). This includes de novo 
sequencing of new microbes (Yin et al 2014), variant calling (Henn et al 2012), advances 
in transcriptomics (Wang et al 2009) as well as various types of meta-analyses 
(Handelsman 2004, Shi et al 2009, Tringe et al 2005).  
c. NGS meta-analyses: targeted, whole-genome and -transcriptome sequencing 
It is important to notice that the term metagenomics, one type of meta-analysis, is often 
incorrectly used in studies involving targeted sequencing, like 16S rRNA gene sequencing 
(Cénit et al 2014, Sankar et al 2015) as well as for studies involving whole-genome 
sequencing (Qin et al 2012). These different types of studies also generate different types 
of results, one being restricted to a specific class of microorganism, i.e. bacteria when 
16S rRNA genes are analysed, and the latter being an unbiased approach in that 
complete microbiomes are identified, including all viral, bacterial, fungal and parasitical 
microorganisms (Human Microbiome Project 2012). The various applications involving 
metagenomics in the frame of this PhD thesis are of the latter type, as it is believed that, 
once fully developed and matured, this type of approach will allow “true” complete sample 
characterisation. 
4. Overarching goals of the PhD 
The overarching goals of this PhD were (i) to assess and review current molecular 
diagnostics tools; (ii) to develop and optimize approaches that could help improving the 
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molecular diagnosis of infectious diseases; and (iii) to validate these approaches with 
different applications.  
The specific objectives were: 
i) To compare “naïve” molecular diagnostics approaches, including multiplexed 
assays, microarrays and meta-analyses based on next-generation sequencing 
(metagenomics and metatranscriptomics). 
ii) To develop a workflow allowing the selection of highly conserved and specific 
molecular markers among highly diverse taxa, which were further used as 
targets for molecular assays. This included the development of the 
bioinformatics pipeline as well as the validation on a set of selected viruses. 
iii) To develop and conduct a proof-of-concept study showing the potential of 
meta-analyses in the field of molecular diagnostics. This proof-of-concept study 
focused on patients with persistent digestive disorders and the potential of 
metagenomics in the context of the rapidly developing area of personalised 
medicine.  
iv) To apply a metagenomics approach in a larger study including both 
environmental and human samples with the aim to assess the impact of 
exposure to wastewater on the gut microbiome of different population groups. 
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Chapter II.  Development and evaluation of a bioinformatics approach for 
designing molecular assays for viral detection 
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1. Abstract 
Background: Viruses belonging to the Flaviviridae and Bunyaviridae families show 
considerable genetic diversity. However, this diversity is not necessarily taken into 
account when developing diagnostic assays, which are often based on the pairwise 
alignment of a limited number of sequences. Our objective was to develop and evaluate 
a bioinformatics workflow addressing two recurrent issues of molecular assay design: (i) 
the high intraspecies genetic diversity in viruses and (ii) the potential for cross-reactivity 
with close relatives. 
Methodology: The workflow developed herein was based on two consecutive BLASTn 
steps; the first was utilized to select highly conserved regions among the viral taxon of 
interest, and the second was employed to assess the degree of similarity of these highly-
conserved regions to close relatives. Subsequently, the workflow was tested on a set of 
eight viral species, including various strains from the Flaviviridae and Bunyaviridae 
families. 
Principal findings: The genetic diversity ranges from as low as 0.45% variable sites over 
the complete genome of the Japanese encephalitis virus to more than 16% of variable 
sites on segment L of the Crimean-Congo haemorrhagic fever virus. Our proposed 
bioinformatics workflow allowed the selection – based on computing scores – of the best 
target for a diagnostic molecular assay for the eight viral species investigated. 
Conclusions/significance: Our bioinformatics workflow allowed rapid selection of highly 
conserved and specific genomic fragments among the investigated viruses, while 
considering up to several hundred complete genomic sequences. The pertinence of this 
workflow will increase in parallel to the number of sequences made publicly available. We 
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hypothesize that our workflow might be utilized to select diagnostic molecular markers for 
higher organisms with more complex genomes, provided the sequences are made 
available. 
2. Introduction  
The genus Flavivirus (RNA virus) includes several species that cause serious human 
diseases. In Flavivirus infections, the first clinical features observed include, but are not 
limited to, fever, myalgia, headaches, and other nonspecific symptoms (Burke and 
Monath 2001, Gould and Solomon 2008, Leyssen et al 2000, Solomon 2004). These 
nonspecific symptoms complicate the identification of the specific causative agent. 
Importantly, Japanese encephalitis virus (JPEV), West Nile virus (WNV), and St. Louis 
encephalitis virus (SLEV) are responsible for larger outbreaks affecting both humans and 
animals (Erlanger et al 2009, Kopp et al 2013, Petersen and Fischer 2012). Other 
emerging zoonotic Flaviviruses, such as the Usutu virus (USUV), might become important 
threats to human health due to their similarities with other human pathogenic viruses, 
such as WNV (Nikolay et al 2011, Vazquez et al 2011). While potential vectors are 
expanding in the northern hemisphere, resulting in sporadic cases of WNV (Mulatti et al 
2014, Nash et al 2001) and USUV infections in birds (Steinmetz et al 2011, Weissenböck 
et al 2002), these infections remain endemic in low- and middle-income countries. New 
research is needed to develop methods for rapid and accurate identification, and to 
validate these diagnostic tests before wider application. Additionally, while other zoonotic 
arboviruses, such as the Rift Valley fever virus (RVFV) and the Crimean-Congo 
haemorrhagic fever virus (CCHFV) within the Bunyaviridae family, cause serious 
diseases in humans, only a limited number of assays are currently available for their 
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identification and there is a lack of standardization in the assays used in routine 
diagnostics laboratories (Anon. , Hujakka et al 2003). 
Virus neutralization tests (VNTs) are usually considered the ‘gold’ standard for the 
diagnosis of infections by these pathogens (Li 2013). VNTs, however, require a cultivation 
step that must be performed in laboratories with high biosafety measures, which are not 
widely available in low- or middle-income countries. Immunoassays are broadly used in 
clinical-diagnostic settings. However, while immunoassays rely on biochemistry to identify 
the presence or concentration of antibodies or antigens, genomic and phylogenetic 
information to understand the route of transmission and biology of these viruses is 
lacking. Various polymerase chain reaction (PCR)-based assays, including real-time 
PCR, have been used successfully in epidemiologic studies (Burt and Swanepoel 2005, 
Grobbelaar et al 2011, Pepin et al 2010). Yet, this variety of assays introduces a lack of 
standardization in the different routine diagnostic laboratories. It is conceivable that taxon-
specific molecular assays, even though system-wide diagnostics studies become more 
and more common (Schneeberger et al 2016), that are relying on genomic information 
might help clinicians and researchers to obtain more accurate epidemiologic baseline 
data for neglected viral infections (Espy et al 2006, Mackay et al 2002, Sloan et al 2008). 
Within the Bunyaviridae family, viruses from the Hantavirus genus are responsible for 
several recent outbreaks (Hartline et al 2013, Montgomery et al 2012, Roehr 2012), but 
reliable molecular assays to trace transmission pathways and to deepen our 
understanding of viral epidemiology have yet to be developed and more widely 
implemented. 
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Genetic diversity among RNA viruses from the Bunyaviridae and Flaviviridae families 
is high compared with that of DNA viruses, as has been shown by new data produced by 
next-generation sequencing technologies (Beerenwinkel et al 2012, Radford et al 2012). 
While the development of molecular assays is quite straightforward, such approaches are 
mainly based on the pairwise alignments of sequences, followed by selection of the most 
conserved region within the aligned sequences. Although alignment algorithms are 
constantly being improved, computational challenges are still encountered when dealing 
with large numbers of sequences. Such molecular assays are of low priority for organisms 
with slow mutation rates because the overall genetic diversity of these organisms remains 
low and few sequences are sufficient to create an accurate representation. In contrast, in 
rapidly mutating viruses, the method may become restrictive because of the small number 
of sequences, which may not necessarily represent the complete genetic diversity within 
the species. Thus, overall, this alignment approach may give rise to two challenges: (i) 
the selected region is only conserved among a few genetic variants and not among the 
complete taxon and (ii) lack of information about the degree of sharing between the 
selected regions and the sequences of other closely related organisms, potentially 
causing cross-reactions. 
We developed a workflow based on the well-established BLASTn algorithm (Altschul 
et al 1990) to address the aforementioned challenges. Subsequently, the workflow was 
tested on a set of viruses from the Flaviviridae and Bunyaviridae families. Our data may 
be applicable for rapid selection of highly conserved and taxon-specific regions for any 
viral family and, perhaps, for other higher organism for which sufficient genomic data are 
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available. This may further improve various nucleic acid-based molecular tools, such as 
real-time PCR or loop-mediated isothermal amplification (LAMP). 
3. Methods 
a. Hardware and software requirements 
Version 2.2.28+ (64 bits) of the standalone BLAST algorithm was employed in the 
workflow. A backbone script written in PERL was utilized to automate the process and to 
parse and retrieve the intermediate and final result files. The workflow was tested on two 
versions of PERL (versions 5.16 x64 and 5.10 x32). Of note, the script will work with any 
other PERL version compatible with the BioPerl package v.1.6.901 (Stajich et al 2002). 
Version 2.3.4 of the Primer3 package (Untergasser et al 2012) was utilized to select 
primers for the real-time PCR assays. For each species, a subset of highly conserved 
fragments (HCFs; n = 2) selected by the workflow was used to design a primer pair for 
real-time PCR analysis. In order to test different assay configurations, we used the “pick 
primers tool” from Primer3 with a primer size range set to 18–24-mer primers, and a target 
amplification product size set between 300 and 400 bp for members of the Flaviviridae 
family. The same “pick primers tool” was used for members of the Bunyaviridae family; 
however, because of the higher genetic variability, the primer size range was adjusted to 
generate 25–30-mer primers, and the amplification product target size was set between 
100 and 400 bp. 
The same sets of HCFs selected for real-time PCR assays were used as the 
amplification target to test LAMP assays. The HCFs for SLEV and USUV were submitted 
to the online LAMP primer design tool Primer Explorer V4 (Fujitsu, Japan; see: 
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https://primerexplorer.jp/). A set of six LAMP primers (F3, B3, FIP, BIP, LoopF, and 
LoopB) was automatically selected for each of the two species. 
To demonstrate the flexibility of this workflow, two different computer configurations 
were used. Configuration “1” was a conventional notebook, running Windows 7 (x64) with 
8 Gigabyte (Gb) of RAM and an i7 quad core CPU to run up to eight BLASTn instances 
in parallel. Configuration “2” was a more powerful workstation running Windows 7 (x64), 
with 32 Gb of RAM and an i7 hexacore CPU able to run up to 12 BLASTn instances in 
parallel. 
b. Input Data Used for the Workflow 
A file containing all publicly available complete genome sequences was downloaded on 
January 17, 2013 for each tested virus species from GenBank (Benson et al 2013). The 
number of sequences available on this date ranged from only six sequences for USUV 
up to 608 sequences for WNV (Table S1). 
c. Phylogenetic Analyses 
Phylogenetic analysis was performed using MEGA v.6.0 software (Tamura et al 2013). 
The ClustalW pairwise alignment algorithm (Larkin et al 2007) was used with default 
parameters, and the trees were generated from the sequence alignments using the 
neighbour-joining approach (Saitou and Nei 1987) with 700 bootstrap replications. 
d. Viral Samples 
Eight viral species from the Flaviviridae and the Bunyaviridae families were used to test 
the results of the workflow. Two WNV strains (i.e., NY99 and Dakar) were included in this 
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study. For the remaining seven viral species, we included a single species sample and 
did not test various strains. The viral samples were obtained from various European 
collections and cultivated using various methods, as reported in Table 1. Upon receipt, 
each virus was propagated in appropriate cell cultures within a biosafety level 3 (BSL-3) 
facility at Spiez Laboratory (Spiez, Switzerland) and virus titres were measured using the 
respective validated rt-qPCR protocols. An aliquot of each sample was stored at -80°C. 
Taxonomy (family, genus, species) Abbreviation Subtype Cell type Origina 
Flaviviridae             
 Flavivirus 
     
  St. Louis encephalitis virus SLEV Type 1 Vero E6 NCPV 
  Usutu virus USUV Bologna Vero E6 UNIBO 
  
Tick-borne encephalitis virus TBEV Hanzalova Porcine kidney 
IP 
ASCR 
  Japanese encephalitis virus JPEV Nakayama Vero E6 NCPV 
  West Nile virus WNV NY99 Vero E6 NCPV 
  West Nile virus  WNV Dakar Vero E6 NCPV 
Bunyaviridae       
 Nairovirus 
     
  
Crimean-Congo hemorrhagic fever 
virus 
CCHFV N.A.b BNI BNI 
 Phlebovirus 
     
  Rift Valley fever virus RVFV H13/96 Vero E6 NCPV 
 Hantavirus 
     
  Seoul virus SEOV R22 Vero E6 NCPV 
Table 1. Virus species used for the validation of the diagnostic assays developed with the 
workflow designed in this study. aNCPV, National Collection of Pathogenic Viruses 
(Porton Down, United Kingdom). BNI, Bernhard-Nocht-Institute for Tropical Medicine 
(Hamburg, Germany). IP ASCR, Institute of Parasitology - Academy of Sciences of the 
Czech Republic (Prague, Czech Republic). UNIBO, University of Bologna (Bologna, 
Italy). bN.A., not available. 
The viral titres were measured as follow: SLEV = 8.1×109 PFU/ml, USUV = 1.35×109 
PFU/ml, TBEV = 1.66×109 PFU/ml, JPEV = 5.34×107 PFU/ml, WNV NY99 = 1.5×1010 
PFU/ml, WNV Dakar = 1.61×1010 PFU/ml, CCHFV = 9.6×108 PFU/ml, RVFV = 9.92×107 
PFU/ml, and SEOV = 4.66×107 PFU/ml. 
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e. Nucleic acid isolation 
Prior to extraction, each cell culture supernatant was concentrated from 1 ml to 100 µl 
using 10-kDa AMICON Ultra centrifugal units (Merck Millipore; Billerica, MA, United 
States of America) at 4,000 × g for 4 min. After concentration, RNA was isolated and 
extracted on an EZ1 Advanced XL platform (Qiagen; Hilden, Germany). The EZ1 Virus 
Mini Kit v2.0 (Qiagen) was used, adhering to the manufacturer’s protocol. 
f. Real-time PCR and LAMP assays 
Real-time PCR assays were performed on a ViiA 7 real-time system (Applied Biosystems; 
Carlsbad, CA, United States of America) using the Power SYBR RNA-to-Ct One-Step kit 
(Thermofisher Scientific; Bremen, Germany). Reverse transcription was performed at 
48°C for 30 min, and samples were subjected to 40 cycles of PCR amplification (95°C for 
15 s and 55°C for 1 min) for flaviviruses. The same conditions were used for the members 
of the Bunyaviridae family, except that 52°C was used for the second step of the cycles, 
instead of 55°C. Amplification was performed in a reaction volume of 50 µl, and 
amplification products were detected using SYBR Green staining. Due to higher 
concentrations for the Flaviviridae, 3 µl from the initial solution was used as a template 
instead of 5 µl for CCHFV, RVFV, and SEOV. A final concentration of 0.2 µM was used 
for both the forward and reverse primers for each reaction. The melting curves were done 
with temperatures ranging from 55°C to 95°C with a ramp rate of 0.05°C/s. LAMP assays 
were performed on a 7500 Fast Real-Time PCR System (Applied Biosystems; Carlsbad, 
CA, United States of America). Isothermal MMX (OptiGene; Horsham, United Kingdom) 
was used at a 1× concentration in a 12-µl reaction volume. Primers were used at the 
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following concentrations: F3 and B3, 0.2 µM; FIP and BIP, 2 µM; and loopF and loopB, 1 
µM. 
4. Results 
a. Workflow Concept 
The presented approach consisted of two consecutive BLASTn steps to assess the 
degree of conservation of a sequence among a taxon of interest and to test for its 
specificity towards closely related organisms, as detailed in Figure 1. 
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Figure 1. Bioinformatics analysis workflow. Input sequences were processed through a 
“dual-BLASTn” pipeline in order to select for the most conserved and at the same time 
specific molecular markers. 
Pre-processing of the whole genomic sequences used as input was carried out in two 
steps. Genomic samples were first fragmented to 400 bp. Because consecutive 
fragments shared an overlap of 390 bp, they allowed accurate representation of the 
various genomic regions for the next processing steps. Two additional filtering steps were 
used to remove sequences showing suboptimal thermodynamic parameters from this 
pool of organism-specific fragments (OSFs). The first filter selected only fragments with 
a GC content of 30–70%, and the second filter checked the remaining fragments for 
homopolymers or repeated regions, which are generally considered inappropriate targets 
for molecular assays. In parallel, genomic sequences in GenBank format were converted 
to Fasta format and further converted into an organism-specific database (OSD) using 
the appropriate tool provided within the NCBI software suite. Subsequently, the first 
BLASTn step was carried out to select the HCFs among the taxon of interest. In order to 
perform this action, OSFs were compared to the OSD. The scores resulting from this 
analysis, including the total amount of hits in the OSD, E-values and bitscores, were 
retrieved in order to assess the degree of conservation of each OSF in the taxon of 
interest. Moreover, OSFs were ranked by decreasing number of hits, decreasing sum of 
bitscores, and increasing sum of E-values. A subset (n = 100) of the fragments with the 
best scores was selected for further analysis. 
The second part of this workflow aimed to assess the specificity of the subset of HCFs 
toward the organism of interest, thus providing information on potential cross-reactions 
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with close relatives. This step consisted of an additional BLASTn step against the NCBI’s 
nt database. In contrast to the ranking system from the previous step, HCFs were ranked 
by increasing number of hits, increasing sums of bitscores, and decreasing E-values, thus 
enabling ranking to be carried out in accordance with the complete database. Hence, this 
step allowed us to assess the specificity of each of HCF and served as an assessment of 
the potential for cross-reactions when using the selected HCFs as targets for molecular 
assays. 
b. Genetic Diversity among the Tested Viruses 
The consensus sequences from 10 and 60 segment L complete sequences from the 
CCHFV were generated in order to assess whether using different numbers of sequences 
could influence the selection of a target for identification assays. For the same reason, 
two consensus sequences from 10 and 153 complete JPEV genomes were also 
generated. The results of these alignments are reported in Table 2. The consensus 
generated from 60 CCHFV sequences had 871 additional ambiguities when compared 
with the consensus generated from 10 CCHFV sequences. This represents 
approximately 16% of the overall length of the consensus (5,372 bp). On the other hand, 
the consensus generated from 153 JPEV sequences had only 48 additional ambiguities 
when compared with the consensus generated with 10 JPEV sequences, suggesting that 
only 0.44% of the genome (10,980 bp) represented variable sites. 
 Consensus 
CCHFV 
Consensus 
JPEV 
Consensus 
CCHFV 
Consensus 
JPEV 
Variation 
CCHFV 
Variation 
JPEV 
Sequences 10 10 60 153 N.A.a N.A. 
Length 
(bp) 
5,370 10,979 5,372 10,980 2 1 
GC (%): 38.18 46.33 30.49 46.45 -7.68 -0.11 
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A (%): 28.29 24.98 23.59 25.17 -4.70 -0.19 
C (%): 18.90 20.13 14.99 20.15 -3.92 -0.02 
G (%): 19.27 26.20 15.51 26.30 -3.77 -0.10 
T (%): 22.09 17.68 17.09 17.81 -5.00 -0.14 
Y (%): 5.51 5.16 11.58 5.11 6.07 0.05 
W (%): 0.73 0.44 1.73 0.40 1.00 0.04 
V (%): 0.02 0.00 0.24 0.00 0.22 0.00 
S (%): 0.04 0.30 0.50 0.26 0.47 0.05 
R (%): 4.41 3.96 10.67 3.73 6.25 0.23 
N (%): 0.02 0.15 0.58 0.16 0.56 -0.02 
M (%): 0.34 0.57 1.62 0.53 1.28 0.05 
K (%): 0.24 0.43 0.60 0.36 0.35 0.06 
H (%): 0.04 0.00 0.73 0.01 0.69 -0.01 
D (%): 0.06 0.00 0.35 0.00 0.30 0.00 
B (%): 0.06 0.00 0.24 0.00 0.19 0.00 
Table 2. Ambiguity-based comparison of consensus sequences generated using different 
amounts of Crimean-Congo hemorrhagic fever virus (CCHFV) or Japanese encephalitis 
virus (JPEV) genomes. aN.A., not applicable. 
c. Workflow Output 
While using configuration 1, it was not possible to align all 608 complete WNV genome 
sequences with the ClustalW algorithm or the MUSCLE algorithm (Edgar 2004). Using 
our workflow allowed us to select candidate molecular markers from different numbers of 
complete genome sequences, from as few as six sequences for USUV to as many as 
608 sequences for WNV. Selected molecular markers were used to generate real-time 
PCR primer sets for the detection of viruses from both the Bunyaviridae and Flaviviridae 
families (Table 3). Because of the lack of published LAMP assays and to demonstrate 
that the molecular markers selected using this workflow were multipurpose, we used the 
HCFs for USUV and SLEV to design LAMP primer sets (Table 4). 
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Species Target Forward primer (5’–3’) Reverse primer (5’–3’) 
Sequence 
number 
Size 
(bp) 
JPEV NSP 5 GGTACTACTGGGGCGAATGG CCAAAAGGGGTGGTGTCAGT 153 342 
SLEV PreMP ACAAGACTGACGCTCAAAGC GGATTGCGCAAAACCCAGTT 8 352 
TBEV NSP 5 ACAGCTAAACTTGCCTGGCT ACGGTTTTTCCACTGCTCCA 42 348 
USUV NSP 5 TCATGGAGCGCTTGGAAGTT CAGGTCCGATATGGGTGGTC 6 343 
WNV NSP 1 ACCAGAACTCGCCAACAACA TCTCAAGGATTCCATCGCCC 608 341 
CCHFV Seg.a L GCATCTCTGAAGTAACTGAAACAACA GTTGAGATAGCACCGAGTTTCTTTAG 41 154 
 Seg. M AGAAACAAGCTTATCAATTGAGGCAC TGTCCTTTCTTCCAGCTTCATAATTG 60 175 
 Seg. S GATGAGATGAACAAGTGGTTTGAAGA GTAGATGGAATCCTTTTGTGCATCAT 65 159 
SEOV Seg. L GTCTCACTTAGTACGAGTAAGGTTGA AATTTTTGTCAGACATGCCTATACCG 7 178 
 Seg. M CCTTGCAACAATTGATTCTTTTCAAT ACAAGGATTCTCAGCCAAATTTTCAA 18 160 
 Seg. S GAAGAAATCCAGAGAGAAATCAGTGC ATTTTTGATTGTATTGAAGCTGCGAC 19 161 
RVFV Seg. L ATGATGAATGACGGGTTTGATCATTT AACCTCATACTTAGCGAGTTTAGTCA 86 150 
 Seg. M GGCCCTTAGAGTTTTTAACTGTATCG GGGCTCTCAATGAAAGAAAAGCTATT 91 192 
 Seg. S AACAATCATTTTCTTGGCATCCTTCT ATAATGGACAACTATCAAGAGCTTGC 141 180 
Table 3. List of selected targets and real-time PCR primer pairs designed for different 
viral species employed in this study. aSeg., segment; WNV, West Nile virus; SLEV, St. 
Louis encephalitis virus; JPEV, Japanese encephalitis virus; USUV, Usutu virus; TBEV, 
Tick-borne encephalitis virus; SEOV, Seoul virus; CCHFV, Crimean-Congo hemorrhagic 
fever virus; RVFV, Rift Valley fever virus. 
Species Primera Primer sequence (5’–3’) Input sequences 
SLEV F3 GAGCACTTGATGTGGGAG 8 
 B3 CAATGATTGCCGAATCGC  
 FIP CTTCCATCCGTAATCCAACTCATCCTGACTTGTCAGTTGTAGTGC  
 BIP AACACATTTGTTGTTGATGGACCCGAGTGAACACCATGCCAA  
 LoopF CCAGCTTCTTCAGGCGTC  
 LoopB CAAGGAGTGTCCAACAGCA  
USUV F3 GCTGCCAATGAATACGGA 6 
 B3 TAGTGGAGGGTAGCCAGA  
 FIP GTGAGAACCACTGTGCTCCCTACCCTCCATGAACGCTT  
 BIP TCAGAATACATCACAACATCTCTGGCGTAGGTTGAACAAAGACCCA  
 LoopF GGTCGCAAATCCAATGCC  
 LoopB TTCAATAAGCGCTCAGGC  
Table 4. List of LAMP primer sets designed for Usutu virus (USUV) and St. Louis 
encephalitis virus (SLEV). aF3 and B3, forward outer and reverse outer primers for LAMP, 
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respectively; FIP and BIP, inner LAMP primers; LoopF and LoopR, forward and reverse 
loop primers. 
 The selected primer pairs were tested against a panel of virus species, including 
two WNV (NY99 and Dakar) strains, as shown in Figure 2. CCHFV was amplified with 
an average between the different genomics segments of 21.9 cycles, RVFV with an 
average of 23 cycles, and SEOV a Ct value average of 27.8. SLEV, WNV NY99, USUV, 
and WNV Dakar reached the threshold between 23 and 26 cycles (23.8, 24.1, 25.3, and 
25.4, respectively). TBEV and JPEV were amplified within 27.8 and 28.1 cycles, 
respectively. The efficiency of the reactions was measured between 82% (RVFV 
Segment M) at the lowest and 141% (JPEV) at the highest. The efficiency of 11 of the 
other 13 reactions was comprised between 90% and 110% except for TBEV (115%) and 
CCHFV Segment S (86%). 
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Figure 2. Real-time PCR assays of members from the Flaviviridae and Bunyaviridae 
families. Amplification and melting curves for five different flaviviruses species are shown. 
Each sample was tested undiluted, with a 10-fold dilution and with a 100-fold dilution. (A) 
St. Louis encephalitis virus (SLEV). (B) Usutu virus (USUV). (C) Tick-borne encephalitis 
virus (TBEV). (D) Japanese encephalitis virus (JPEV). (E) West Nile virus (WNV; 2 
strains, NY99 and Dakar). The right half of the panel shows the amplification and melting 
curves of the different genomic segments of the members from the Bunyaviridae family 
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tested in this study. (F) Crimean-Congo hemorrhagic fever virus (CCHFV). (G) Rift Valley 
fever virus (RVFV). (H) Seoul virus (SEOV). NTC, no template control; RFU, relative 
fluorescence units; Ct, cycle threshold; Dil., dilution; Seg., Segment. 
A phylogenetic tree of the Flaviviridae family was generated, as shown in Figure 3, 
in order to test for cross-reactivity between the closest relatives, namely JPEV, USUV, 
and WNV. As previously shown, fragments of all three species were amplified using the 
corresponding primer sets at 28.1 cycles for JPEV, 25.3 cycles for USUV, and 24.1 cycles 
for WNV (NY99). 
There was no cross-amplification when mixing the JPEV template with the primer 
pairs selected for USUV and WNV. Similarly, for WNV, amplification occurred only with 
the corresponding WNV primers and not with the USUV or JPEV primer pairs. However, 
while there was no amplification with the USUV template and WNV primers, there was 
amplification when using JPEV primers around cycle 29. 
In order to make sure that this cross-reaction does not involve the selection of the 
target regions but rather the selection of the primer pairs designed to amplify this region, 
we sequenced the amplicons from the three relevant reactions, namely (i) the JPEV 
template amplified with JPEV primers; (ii) the USUV template amplified with JPEV primers 
and (iii) the USUV template amplified with USUV primers (S1 Supporting Information). 
The obtained sequences were compared to the NCBI database and the USUV template 
amplified with the USUV primers showed 61.8% identity with JPEV genomic sequences 
and 70.3% identity when using the primer pair selected for JPEV. 
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Figure 3. Testing cross-reactions between a set of close relatives from the Flaviviridae 
family. West Nile virus (WNV), Japanese encephalitis virus (JPEV), and Usutu virus 
(USUV) were tested. (A) Phylogenetic analysis of a subset of 6–10 sequences from 
members of the Flaviviridae family. (B) Real-time amplification of viruses with master 
mixes containing different primer pairs. RFU, relative fluorescence units; Ct, cycle 
threshold. 
 Both USUV and SLEV were successfully amplified with corresponding LAMP 
assay primers. Amplification occurred after 46 min for SLEV RNA, including the reverse 
transcription step. The LAMP primer set selected for USUV successfully amplified the 
template within 40 min, also including the reverse transcription step (Figure 4). The 
included controls excluded the formation of primer dimers, which is likely to happen due 
to the nested nature of LAMP assays. 
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Figure 4. Loop-mediated isothermal amplification of Usutu virus (USUV) and St. Louis 
encephalitis virus (SLEV). NTC, no template control; RFU, relative fluorescence units; Ct, 
cycle threshold. 
5. Discussion 
We developed and evaluated a bioinformatics workflow that readily addresses the high 
intra-species genetic diversity of viruses and takes into consideration the potential for 
cross-reactivity between close relatives. These are two key issues that complicate the 
design of molecular assays (Avise 2012, Espy et al 2006). Our workflow allowed for rapid 
selection of highly conserved and specific genomic fragments among the investigated 
viruses, while considering up to several hundred complete genomic sequences. 
With the advent of next-generation sequencing, an increasing number of sequences 
have been, and continue to be, made publicly available (Montgomery et al 2012, 
Stephens et al 2015). Although this has greatly improved our knowledge of the dynamics 
of viral populations, the massive amount of data available also renders bioinformatics 
analysis more complex. In the case of CCHFV, for example, the difference in the 
consensus sequences between analyses utilizing 10 and 60 genomic sequences was 
17.39%, which is a challenge for selecting an appropriate target for a molecular assay. 
For JPEV, the amount of variable positions was much lower, only representing 0.45% of 
the complete genome; nonetheless, 50 additional ambiguities were observed throughout 
the whole consensus. Yet, even such a small difference might still negatively influence 
the performance of a molecular assay by affecting the thermodynamic parameters of the 
reaction, particularly the primer annealing step. 
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Aligning a few genomic sequences is usually straightforward with widely available 
bioinformatics tools (Ferreira et al 2014, Wen et al 2014). In the case of organisms that 
have not been as thoroughly sequenced, alignment may not be an issue at all because 
all available variants may simply be included in the alignment; thus, the overall genetic 
diversity is considered. In the case of extensively sequenced organisms, however, the 
issue of “masked” diversity might rise, since only a subset of all the available sequences 
will be selected for the alignment and finally only a subset of the genetic diversity is taken 
into account for the design of the molecular assay. By using reproducible computing 
scores, including bitscores, E-values, and the number of “hits” in a database, the workflow 
also removed the potential bias that could be introduced by manual selection of an 
adequately amplified region by the user. This workflow allowed us to select highly specific 
molecular markers in less than an hour for all tested viruses using the more powerful 
configuration 2. In order to assess the impact of the hardware, we ran the workflow with 
a single species on both configurations. While the task could be successfully completed 
on both computer platforms, we noted a drop in the time requirement of approximately 
30% from configuration 1 to 2. This drop-in performance was thought to be due to the 
well-optimized parallelization capacity of the BLASTn algorithm. Therefore, we expected 
that the overall runtime could be reduced by increasing the number of CPU cores and 
providing sufficient RAM. In future studies, we will examine the importance of this feature 
in terms of increased sequencing capacity and the increased resulting genomic data 
generated every year (Stephens et al 2015). The performance of this workflow will also 
allow rerunning the analyses when new sequences for a given species of interest become 
available. This would facilitate identification of shifts in the viral population and could 
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reveal whether previously selected molecular markers are still valid (i.e., to keep the 
molecular assay up-to-date and to have it further refined as new data become available). 
In specific cases, if enough sequences are available, this workflow could also be utilized 
to generate strain-specific molecular markers. Having strain-specific assays, particularly 
in the case of neglected tropical diseases, could be a great asset when 
tracking/investigating transmission events and risk factors, in resource-constrained 
settings (Fankhauser et al 2002, Van Belkum et al 2001). This workflow also has the 
advantage of manual design, and hence, it can be entirely customized to the needs of the 
user. In fact, the output from the workflow only depended on the input sequences, and 
the user should be able to select, for example, only geographically related strains to 
design a “geographically specific” assay in order to quickly demonstrate whether 
outbreaks are caused by a new or re-emerging pathogen (Knowles and Samuel 2003). 
All molecular markers that were selected with the workflow could be used as inputs 
for primer design. Real-time PCR assays were all performed successfully, from the single 
amplification target selected for the flaviviruses to the three regions selected for each 
genomic fragment of the members from the Bunyaviridae family. Similarly, the same 
markers selected for USUV and SLEV were successfully used to design LAMP primer 
sets, and the corresponding LAMP assays performed well. These assays confirmed that 
the first BLASTn step of this workflow functioned well for selecting highly conserved 
regions among a pool of species-specific fragments. 
The results generated within this study offer a preliminary overview of the assays 
sensitivity and specificity. However, additional experiments would be required to optimize 
these assays, especially concerning the efficiency of reaction. In general, the melting 
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curves show a high specificity, except for WNV for which some primer-dimers seem to be 
forming. Regarding the suboptimal efficiencies, one lead to optimize could be to remove 
either inhibitors (especially in the case of JPEV and TBEV, which show an increased 
reaction efficiency), test various primer concentrations as well as a range of more 
adapted, reaction-specific, PCR conditions. 
In order to further improve this workflow, we added a second BLASTn step to assess 
the degree of sharing of highly conserved species-specific fragments in a general 
database also containing genomic data from close relatives. The tested cross-reactions 
showed that the primers selected for WNV and USUV were specific for those species, 
whereas the JPEV primers cross-reacted with the USUV template, but not with the WNV 
template. In order to determine whether this cross-reaction occurred because of the 
primers or poor selection of the molecular markers, we used Sanger sequencing to 
sequence the amplicons from the two USUV reactions (both with USUV and JPEV 
primers) and the JPEV reaction (with the JPEV primers). Sequencing revealed that the 
amplified regions (i.e., the selected molecular markers) were highly specific to their 
corresponding species. An online BLASTn of the JPEV primers against USUV sequences 
showed that the forward primer had nine nucleotides matching the USUV virus at the 3′ 
end and 19 common nucleotides on the reverse primer (only one mismatch, data not 
shown). This issue highlights two additional controls that should be performed using this 
workflow after selecting the target regions, namely (i) an additional online BLASTn control 
of the primer selected by the various software programs, be it for real-time PCR or LAMP 
assays, and (ii) since cross-reactions are difficult to predict, the designed assay should 
be tested with a gradient PCR first to ensure that the thermodynamic parameters of the 
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reaction are optimal. However, sequencing of the amplification product is still considered 
the ‘gold’ standard for validating the molecular assay and ensuring high specificity of the 
assay. 
In conclusion, the workflow presented here for viral detection provides a promising 
approach as it addresses the recurrent issue of bioinformatics analysis of large amounts 
of sequencing data, which is expected to be an even greater challenge as publicly 
available data are rapidly increasing. This workflow removes user-introduced bias by 
being solely based on well-established computing scores (bitscore, E-value, and number 
of hits). Hence, our workflow addresses two issues encountered in the manual design of 
a molecular assay, as it takes into account the complete genetic diversity of an organism, 
and provides timely information on potential cross-reactions. We speculate that our 
workflow is applicable to a variety of DNA-based assays, and hence, it should 
theoretically work for higher organisms, such as bacteria or parasites, facilitating the 
selection of future diagnostic markers. 
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Supplementary S1 
>Usutu virus template with JPEV primers 
gaGgagggTTaACCTTGgAAGTGGAACaAGAGCCGTTGGGAAACCCCaGcCACATACC
AACcaGGAGAAGaTTAAAGCcaGGATTCAAAGATTGAAAGAGGAGTATGCAGCCACA
TGGCACCACGATAAGGACCACCCATATCGGACCTGgaCCTACCACGGAAGTTATGA
AGTGAAACCGACCGGTTCAGCAAGCTCCTTGGTCAACGGAGTTGTCCGCCTAATG
AGCAAGCCCTGGgATGCAATTCTCAACGTgaCCACCATGGCGATGACTGACAccaCC
CTTTTGGa 
>Usutu virus template with USUV primers 
tTtcaAccaTGAGatgTACTGGGTCAGTGGAGCTGCTGGCAACatTGTCCACGCAGTGA
ACATGACGAGTCAAGTGCTCATAGGGCGAATGGAGAAGAGAACATGGCATGGACC
AAAATACGAGGAGGATGTTAACCTTGGAAGTGGAACAAGAGCCGTTGGGAAACCC
CAGCCACATACCAACCAGGAGAAGATTAAAGCCAGGATTCAAAGATTGAAAGAGG
AGTATGCAGCCACATGGCACCACGATAAGGACCACcctacgGACCtggaa 
>Japanese encephalitis virus template with JPEV primer 
gtatgagGagaTTCACCTAGGgagCGGAGAGCCGTGGGAAAGGGAGAAGTCCATAGCA
ATCAGGAGAAAATCAAGAAGAGAATCCAGAAGCTTAAAGAAGAATTCGCCACAACg
TGGCACAAAGACCCCGAGCATCCATACCGTACTTGgACATACCACGgaAGCTATGA
AGTGAAGGCTACTGGCTCAGCCAGCTCTCTCGTCAATGGAGTGGTGAAGCTCATG
AGCAAACCTTGGGACGCCATCGCCAACGTCACCACCATGGCCATGACTGACACCa
cCCCTTTTGGa 
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1. Abstract 
The complete genome sequence of a highly divergent strain of Grapevine leafroll-
associated virus 4 (GLRaV-4) was determined using 454 pyrosequencing technology. 
This virus, designated GLRaV-4 Ob, was detected in Vitis vinifera cv. Otcha bala from 
our grapevine virus collection at Agroscope. The GLRaV-4 Ob genome length and 
organization share similarities with members of subgroup II in the genus Ampelovirus 
(fam. Closteroviridae). Otcha bala was graft-inoculated onto indicator plants of cv. Gamay 
to evaluate the biological properties of this new strain, and typical leafroll symptoms were 
induced. A monoclonal antibody for the rapid detection of GLRaV-4 Ob by enzyme-linked 
immunosorbent assay (ELISA) is available, thus facilitating large-scale diagnostics of this 
virus. Based on the relatively small size of the coat protein, the reduced amino acid 
identity and the distinct serological properties, our study clearly shows that GLRaV-4 Ob 
is a divergent strain of GLRaV-4. Furthermore, molecular and serological data revealed 
that the AA42 accession from which GLRaV-7 was originally reported is in fact co-infected 
with GLRaV-4 Ob and GLRaV-7. This finding challenges the idea that GLRaV-7 is a 
leafroll-causing agent. 
2. Introduction 
Similar to other woody perennial crops, grapevines (Vitis spp.) are prone to infection by 
diverse viruses. Currently, more than 60 viruses have been reported to infect grapevines 
(Martelli 2014). Grapevine leafroll disease (GLRD) is one of the most economically 
important viral diseases of grapevines, and its effects on yield and harvest quality have 
been documented for several grapevine cultivars (Komar et al 2010, Lee and Martin 2009, 
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Mannini et al 2012, Spring et al 2012). Cultivars infected with GLRD generally exhibit yield 
reduction and poor fruit quality. For red grape cultivars, one of the primary effect of GLRD 
is lower anthocyanin accumulation, thus resulting in poor berry colour development. For 
white cultivars, GLRD symptoms are visually less evident; however, infected grapevines 
may show chlorotic mottling of leaves toward the end of the growing season. 
GLRD has a complex aetiology associated with different filamentous viruses 
referred to as grapevine leafroll-associated viruses (GLRaVs). All GLRaVs identified to 
date belong to the family Closteroviridae. In total, 5 different GLRaV species have been 
identified: one in the genus Closterovirus (GLRaV-2), three in the genus Ampelovirus 
(GLRaV-1, GLRaV-3 and GLRaV-4) and one in the recently defined genus Velarivirus 
(GLRaV-7) (Al Rwahnih et al 2012). The genus Ampelovirus is further divided into 
subgroup I, consisting of GLRaV-1 and GLRaV-3 and subgroup II, consisting of all the 
genetically divergent GLRaV-4 strains (Abou Ghanem-Sabanadzovic et al 2012). 
According to the most recent taxonomic revision of the genus Ampelovirus, GLRaV-5, 
GLRaV-6, GLRaV-9, GLRaV-Pr and GLRaV-Car were classified as strains of GLRaV-4 
and not, as had been previously assumed, as distinct species in the genus Ampelovirus 
(Abou Ghanem-Sabanadzovic et al 2010, Abou Ghanem-Sabanadzovic et al 2012, 
Maliogka et al 2009, Martelli et al 2012).  
Herein, we report the description of a filamentous virus infecting a grapevine 
accession and showing leafroll symptoms when grafted onto cv. Gamay indicators. We 
present its complete genome sequence, describe the genome organization and 
serological features, and show that this virus is a highly divergent strain of GLRaV-4. 
Finally, using a combination of serological and molecular diagnostic techniques, we show 
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that accession AA42 is co-infected with GLRaV-7 and GLRaV-4 Ob. The implication of 
these findings for leafroll aetiology is discussed. 
3. Materials and methods 
a. Virus isolates and biological indexing 
The primary grapevine materials used for this study were collected from the grapevine 
virus collection at Agroscope in Nyon (Switzerland), which contains more than 600 clones 
of distinct plant accessions (Gugerli et al 2009a). Three cuttings from the Otcha bala 
grapevine accession (Nos. 10,496, 10,497, and 10,498) were used for biological, 
serological and molecular characterization. Additional grapevine accessions used for this 
study included AA42, Y276 and Chiliaki Chjornyj, which were kindly provided by W. 
Jelkmann, O. Lemaire and the National Institute of Agrobiological Sciences (Japan), 
respectively. The accession Chiliaki Chjornyj was shown to be coinfected by GLRaV-7 
and GLRaV-4 strain Ru (Ito et al 2013). Three additional GLRaV-7-infected accessions 
were provided by A. Rowhani from UC Davis: Siar, Takhani and Sultanina rose. Using 
microsatellite analysis, the cultivar identity of the Otcha bala plant accession was verified, 
and grapevine accession AA42 was identified as the grapevine cultivar Sultanine (E. 
Droz, personal communication). 
Otcha bala canes were graft-inoculated onto the leafroll-specific indicator Vitis 
vinifera cv. Gamay Rouge de la Loire. Eight replicates were planted in the field, and 
symptoms were evaluated over a 3-year period. Graft-inoculated GLRaV-1-infected vines 
were grown as positive controls. 
b. Virus particle purification and serology 
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Virus particles were purified from mature leaves as described previously (Gugerli et al 
1984). Purified virus particles were observed using a Philips CM10 transmission electron 
microscope, as described by Gugerli and Ramel (Gugerli and Ramel 2004).  
A cell line producing the monoclonal antibody MAb37a was generated against 
viruses purified from accession Y276 (Rigotti et al 2006). The serological tests used in 
this study consisted of double antibody sandwich enzyme-linked immunosorbent assays 
(DAS-ELISAs), immunoprecipitation electron microscopy (IPEM) and Western blot. 
These tests were performed essentially as described previously (Gugerli and Ramel 
2004).  
Commercially available ELISA kits (GLRaV-1 DAS, GLRaV-2 DAS, GLRaV-3 DAS 
and GLRaV-6 DAS from Bioreba AG, Switzerland) were used to screen for the indicated 
grapevine leafroll-associated viruses according to the manufacturer’s instructions. DAS-
ELISAs using reference antisera and monoclonal antibodies developed at Agroscope 
were used to test for GLRaV-4 infection. Briefly, ELISA plates were first coated with rabbit 
antiserum (1 µg/ml) in carbonate buffer and then incubated with grapevine crude leaf 
extracts for 16 hours at 6°C. Then, the wells were washed, and alkaline phosphatase-
conjugated monoclonal antibodies were added. To detect GLRaV-4, GLRaV-4 strain 5 
and GLRaV-4 strain 9, the following monoclonal antibodies were used: MAb 3-1, MAb 3-
3 and MAb 27-1, respectively (Besse et al 2009, Gugerli et al 2009b). The reaction with 
the chromogenic substrate p-nitrophenyl phosphate was performed at room temperature, 
and the absorbance at 405 nm was read using a spectrophotometer after 3 hours. 
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c. Nucleic acid extraction, RT-PCR amplification and Sanger sequencing 
Total RNA was extracted from mature leaf petioles using RNeasy Plant Mini Kits (Qiagen, 
Germany). One-step reverse transcription-polymerase chain reaction (RT-PCR) was 
performed using the AMV reverse transcriptase (Promega, Germany) and GoTaq 
polymerase (Promega, Germany) with total RNA as the template. RT-PCR was 
performed with primer pairs specific for each virus using the conditions described in the 
original publications (Supplementary Table 1).  
For sequencing purposes, purified PCR products were cloned into the vector 
pGEM-T (Promega, Germany) and were sequenced at Fasteris SA (Switzerland). To 
sequence the 3’-end of the GLRaV-4 Ob genome, viral RNAs were polyadenylated using 
an A-Plus Poly (A) Tailing Kit (Epicentre Biotechnologies, Madison, USA), and the tailed 
viral RNA was used as the template in a reverse-transcription reaction. Sequences of the 
5’ and 3’ viral termini were obtained using a 5’/3’ RACE kit (Roche). Two independent 
clones were sequenced from each 5’ and 3’ terminus.  
d. Viral particle enrichment, pyrosequencing, assembly and sequence analyses  
Purified viral particles were treated with nucleases (DNase and RNaseA) to remove Vitis 
DNA and RNA contaminants. Then, viral RNA was extracted from purified viruses using 
RNeasy Plant Mini kits (Qiagen, Germany) and randomly amplified using a Whole 
Transcriptome kit (Sigma-Aldrich) for sequencing on a Roche 454 GS Junior platform 
(Roche Diagnostics Corp., Branford, CT). Sequencing libraries were prepared with a 
Rapid Library Preparation kit according to the manufacturer’s protocol and sequenced on 
one PicoTiter plate using Titanium chemistry. Quality control analysis and assembly of 
 78 
 
the produced reads were performed using DNASTAR’s NGen assembler (Madison, USA) 
with 454-specific parameters. Filtered reads were converted to fasta files and subjected 
to BLASTN analysis (Altschul et al 1997) with the GenBank non-redundant nucleotide 
database using decreasing wordsize options of 400, 200, 100, 50 and 28. 
Gene annotation was performed following a comparison with sequences from 
other leafroll-associated viruses and using GeneMarkS software (Besemer and 
Borodovsky 2005). Amino acid and nucleotide alignments were created using ClustalW 
(Goujon et al 2010). The sequences and accession numbers of the viral species/strains 
used for the amino acid sequence comparisons with GLRaV-4 Ob are provided in 
Supplementary Table 2. The phylogenetic relationships were determined using Molecular 
Evolutionary Genetic Analysis software MEGA version 6 with the best amino acid 
substitution model (Tamura et al 2013). Phylogenetic trees were generated using the 
maximum likelihood algorithm with 500 bootstrap replicates.  
4. Results 
a. Electron microscopy and biological indexing 
Viral particles were isolated from leaf samples of the Otcha bala accession. Electron 
micrographs showed filamentous particles consistent with the family Closteroviridae, with 
the most frequent length being 1600 nm (data not shown). The presence of leafroll 
disease was assessed by biological indexing onto the leafroll-specific indicator cv. 
Gamay. Mild leafroll symptoms, including reddening and down curling of the leaves, were 
observed during the 3 consecutive years following the graft inoculation (Figure 1).  
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Figure 1. Leafroll symptoms on Gamay graft-inoculated with Otcha bala accession: A. 
downward curling o leaf margins and B. interveinal red coloration. 
Original Otcha bala accessions and graft-inoculated Gamay plants repeatedly 
tested negative for GLRaV-1, GLRaV-2 GLRaV-3, GLRaV-4 (and its strains 5, 6, and 9) 
viruses by ELISA, thus justifying further investigation to characterize the cause of the 
disease. 
b. Molecular characterization by pyrosequencing  
RNA isolated from virus particles purified from the Otcha bala grapevine was submitted 
to 454 high-throughput sequencing. The analysis yielded 59,087 high-quality reads with 
an average read length of 430 bp. In total, 13,173 reads were de novo assembled into a 
12,882-nt contig with homology to members of the Closteroviridae family. The coverage 
over this contig ranged from 1- to 1918-fold, as shown in Figure 2. 
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To verify the results provided by deep sequencing, specific primers were designed 
using the pyrosequencing data (Supplementary Table 3). Sanger sequencing of PCR 
products validated the pyrosequencing results. Completion and polishing of the 
sequence’s termini was performed by RACE PCR using Otcha bala cDNA as the 
template. RACE sequencing of viral termini led to the modification of the 12,882-nt initial 
contig’s extremities, resulting in a complete genome length of 12,849 nt. The genome 
sequence was deposited in the GenBank database under accession number KP313764. 
Virus-derived fragments were identified in the total fragment pool based on their 
similarities to the nucleotide sequences archived in GenBank using BLASTN. The 
closterovirus-like virus, which we propose to name GLRaV-4 Ob, was the most prevalent 
species among the 454 dataset (Table 1).  
Virus species Virus family Total hits 
Grapevine leafroll-associated virus 4 
Ob 
Closteroviridae 19,572 reads 
Grapevine fleck virus Tymoviridae 9,002 reads 
Grapevine red globe virus Tymoviridae 2,687 reads 
Grapevine virus A Betaflexiviridae 111 reads 
Table 1. High-throughput sequencing reads for viral species identified from the Otcha 
bala grapevine using BLASTN analysis. 
Three other viruses were also identified in the 454 dataset: two viruses of the family 
Tymoviridae (Grapevine fleck virus [GFkV] and Grapevine red globe virus [GRGV]) and 
one member of the Betaflexiviridae (Grapevine virus A [GVA]). No other closterovirus-
related reads were identified from the 454 run. The presence of these viral species was 
confirmed by specific RT-PCR analysis or ELISA. 
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The GLRaV-4 Ob genome is 12,849 nt in length and contains six putative open 
reading frames (ORFs) (Figure 2).  
 
Figure 2. Sequence coverage and nucleotide positions along the Grapevine leafroll-
associated virus 4 strain Ob (GLRaV-4 Ob) genome. The schematic representation of the 
GLRaV-4 Ob genome organization is presented to scale. Putative open reading frames 
(ORFs) are shown in boxes: ORF1a with corresponding domains: Pro = protease, MET 
= methyltransferase, AlkB = 2OG-Fe(II) oxygenase domain, HEL = helicase; ORF1b = 
RNA-dependent RNA polymerase; ORF2 = small 5 K protein; ORF3 = heat shock 70 
protein homolog; ORF4 = 60 K; ORF5 = coat protein; and ORF6 = 23 K protein. 
The GLRaV-4 Ob genome starts with a short 37-nt-long non-coding region. ORF1a 
encodes a polyprotein (2076 aa). Different domains were identified in ORF1a, including 
a methyltransferase (MET, pfam 01660, Pfam database 27.0 (Finn et al 2014)), AlkB 
(pfam 03171) and helicase (HEL, pfam 01443). Additionally, ORF1a contains a papain-
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like protease domain with the catalytic residues Cys225 and His268 and a predicted 
cleavage site after Gly285 (Peng et al 2001). 
ORF1a terminates with the sequence auguuUAG (the stop codon of ORF1a is 
shown in capital letters, while the start codon of ORF1b is underlined); this sequence is 
presumably involved in a +1 ribosomal frameshift as described for other closteroviruses 
(Dolja et al 2006). ORF1b overlaps the last 8 nt of ORF1a and potentially encodes a 526-
aa-long protein. ORF1b shows high homology to the RNA-dependent RNA polymerase 
(RdRp) domain (pfam 00978). The small ORF2 partially overlaps ORF1b by 26 
nucleotides and potentially encodes a 46-aa-long hydrophobic protein (p5). ORF3 is 
situated downstream of p5 after a 144-bp intergenic region and encodes a 533-aa 
HSP70-homolog (HSP70h) protein similar to other sequenced GLRaV-4s. ORF4 partially 
overlaps the previous ORF and encodes a 546-aa-long protein homologous to the p60 
proteins of other closteroviruses. After a 69-nt-long intergenic region, ORF5 encodes a 
261-aa-long protein corresponding to a viral coat protein (CP). The 3’-end proximal ORF 
(ORF6) encodes a putative p23 protein. ORF6 is in accordance with similarly positioned 
small peptides encoded by other closteroviruses at the genome’s 3’ end (Dolja et al 2006). 
The genome ends with a 131-nt-long 3’ non-coding region. 
c. Serological characterization 
The monoclonal antibody MAb37a reacted with Otcha bala grapevine extracts in a DAS-
ELISA (Figure 3).  
 83 
 
 
Figure 3. Specific detection of Grapevine leafroll-associated virus 4 strain Ob (GLRaV-4 
Ob) in crude leaf extracts of different grapevine accessions by homologous double 
antibody sandwich enzyme-linked immunosorbent assays using Mab37a (four samples 
were analysed for each accession; error bars represent standard deviations). Reverse 
transcription-polymerase chain reaction results using GLRaV-4 Ob- and GLRaV-7-
specific primer pairs are shown underneath for each accession (+, specific positive 
amplification: -, no amplification). Leaf extracts from GLRaV-4 strain 9-infected Cabernet 
sauvignon and a healthy grapevine were also tested. The absorbance was read after a 
3-h incubation with the substrate. 
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Otcha bala leaf extracts produced OD values 30 times higher than healthy controls 
after 3 hours of incubation. MAb37a was highly specific because it did not react with other 
GLRaV-4-like viruses (i.e., GLRaV-4, GLRaV-4 strain 5, GLRaV-4 strain 6 and GLRaV-4 
strain 9) from infected grapevines in our collection.  
MAb37a activity was further assayed by immunoprecipitation electron microscopy. 
The filamentous virions of the Otcha bala grapevine were heavily decorated with MAb37a 
(Figure 4). 
 
Figure 4. Immuno-
precipitation electron 
microscopy of Grapevine 
leafroll-associated virus 
4 strain Ob virions 
decorated with Mab37a. 
In Western blot analysis, MAb37a reacted to a dominant protein with an estimated 
molecular mass of approximately 33,000 Da (Figure 5). 
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Figure 5. Detection of the Grapevine leafroll-associated virus 4 strain Ob by western blot 
analysis with Mab37a. M, molecular mass marker in Daltons. 
d. RT-PCR assays and GLRaV-4 Ob survey of Agroscope virus collection 
A DAS-ELISA assay using MAb37a was used to monitor the prevalence of GLRaV-4 Ob 
in our grapevine virus collection. An RT-PCR test targeting the HEL domain of ORF1a of 
GLRaV-4 Ob was developed using GLRaV-4 Ob-F/R primers (Supplementary Table 1) 
to confirm the infection status. Three other accessions from our collection tested positive 
for GLRaV-4 Ob by ELISA and by RT-PCR: Chiliaki Chjornyj, Y276 and AA42 (Fig. 5). To 
ascertain viral infection, amplicons from these accessions were sequenced, yielding 
nucleotide sequences with 88 to 96% identity to GLRaV-4 Ob. The three accessions 
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infected with GLRaV-4 Ob were also tested with the primer set LRamp-F/R reported by 
Abou Ghanem-Sabanadzovic (2012). With this primer set, a fragment with the expected 
size was amplified from all three accessions (data not shown). Amplicons were 
sequenced to verify the specificity of PCR products: amplicon sequence identity varied 
from 88% to 98%. 
Because Ito et al. (Ito et al 2013) reported a mixed infection of GLRaV-4 and 
GLRaV-7 in a grapevine, we decided to evaluate the GLRaV-7 infection status of the 
different materials used in this study. GLRaV-7 infection was assessed by RT-PCR using 
different pairs of specific primers. Each RT-PCR amplification product was sequenced to 
verify its identity. Six accessions tested positive for GLRaV-7 (Fig. 5). The accessions 
Chiliaki Chjornyj, Y276 and AA42 were co-infected with GLRaV-4 Ob and GLRaV-7. The 
Otcha bala accession repeatedly tested negative for GLRaV-7 by RT-PCR using 5 
different primer pairs. 
5. Discussion 
Grapevine leafroll disease has a complex aetiology; different viral species belonging to 
different genera in the family Closteroviridae are associated with the disease (Martelli 
2014). In this study, we described the infection of an Otcha bala grapevine accession 
from our viral collection by clostero-like virus particles. Graft-inoculation of this grapevine 
accession to the leafroll-indicator Gamay resulted in typical leafroll symptoms. To identify 
the virus responsible for the leafroll symptoms, we characterized the virome of the Otcha 
bala accession using a pyrosequencing approach. De novo assembly generated a 
consensus sequence and revealed the presence of a divergent strain of GLRaV-4, which 
we propose to name GLRaV-4 Ob. Four viruses were identified in the diseased Otcha 
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bala grapevine, including GLRaV-4 Ob in the family Closteroviridae. However, GLRaV-4 
Ob was the only closterovirus detected in this vine; therefore, this virus was considered 
to be the agent responsible for the leafroll symptoms observed on the Gamay grapevine.  
Similar to other viruses in the family Closteroviridae, the GLRaV-4 Ob genome possesses 
two large gene modules. One module is responsible for genome replication (MET, HEL 
and RdRp), whereas the other module includes five genes (p5, HSP70h, p60, CP and 
p23) responsible for intercellular transport and virion assembly (Dolja et al 2006). GLRaV-
4 Ob’s genomic organization and size are similar to viruses of subgroup II of the genus 
Ampelovirus (Martelli et al 2012, Thompson et al 2012). For example, the p23 ORF of 
GLRaV-4 Ob does not show any significant homology with CP ORFs and does not contain 
a closterovirus coat protein domain (pfam 01785). Thus, minor CP (CPm) is absent in 
GLRaV-4 Ob, as in all other GLRaV-4 strains (Naidu et al 2014). In contrast, members of 
subgroup I of the genus Ampelovirus, such as GLRaV-1 and GLRaV-3, all possess at 
least one CPm ORF in their genomes (Maree et al 2013). Furthermore, GLRaV-4 Ob 
consistently grouped with viruses of the GLRaV-4 cluster in subgroup II of the genus 
Ampelovirus in phylogenetic analyses performed on the HSP70h gene (Figure 6). 
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Figure 6. Unrooted phylogram constructed using a multiple alignment of heat shock 70 
protein homolog amino acid sequences from some members of the genera Ampelovirus 
and Velarivirus. The scale represents 0.2 amino acid substitutions per site. The 
percentage of replicate trees in which the associated taxa clustered together in the 
bootstrap test is shown next to the branches. 
Despite sequence similarity with other GLRaV-4 strains, GLRaV-4 Ob has several 
genomic features that differentiate this strain from others. i) This virus contains the 
smallest genome among viruses associated with grapevine leafroll disease. ii) The length 
of the RdRp ORF in GLRaV-4 Ob is larger than that in other GLRaV-4 strains (Table 2).  
 RdRp HSP70h CP 
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Identity 
(%) 
 
Size (aa) 
 
Identity 
(%) 
 
Size (aa) 
 
Identity 
(%) 
 
Size (aa) 
GLRaV-4 Ob  526  533  261 
GLRaV-4 AA42 98 *189 98 *173 93 261 
GLRaV-4 strain Ru1 n.a. n.a. 94 *520 93 261 
GLRaV-4 strain Ru2 n.a. n.a. 94 *520 98 261 
GLRaV-4 74 517 71 533 77 272 
GLRaV-4 strain 5 76 517 69 533 78 269 
GLRaV-4 strain 6 78 517 69 533 76 269 
GLRaV-4 strain 9 76 517 70 533 75 272 
GLRaV-4 strain Pr 77 517 69 533 78 273 
GLRaV-4 strain Car 76 516 68 534 77 267 
PMWaV-1 58 525 59 509 57 257 
PMWaV-3 56 525 60 533 67 262 
PBNSPaV 38 525 50 529 30 325 
GLRaV-3 33 533 33 549 15 313 
Table 2. Amino acid sequence identities and the sizes of different genome products 
from viruses of the genus Ampelovirus. n.a.: not available; *: partial sequence. 
iii) The p5 ORF of GLRaV-4 Ob overlaps the RdRp ORF, whereas other members 
of the GLRaV-4 cluster have an intergenic region between those two ORFs (Abou 
Ghanem-Sabanadzovic et al 2012, Thompson et al 2012). Other ampeloviruses that 
share these features with GLRaV-4 Ob include Plum bark necrosis stem pitting-
associated virus (PBNSPaV) and Pineapple mealybug wilt-associated viruses 1 and 3 
(PMWaV-1 and PMWaV-3) (Melzer et al 2008, Sether et al 2009).  
MAb37a was raised against accession Y276, which was initially thought to be 
infected only by GLRaV-7, and was therefore reported to be specific to GLRaV-7 (Rigotti 
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et al 2006). In this work, the double infection (GLRaV-7 and GLRaV-4 Ob) of the Y276 
source was demonstrated. Western blot analysis indicated that MAb37a reacted to a 
structural protein with an apparent molecular weight of approximately 33 kDa (Fig. 4). 
Coat proteins of other GLRaV-4 strains have been reported to have similar molecular 
weights ranging from 31 to 35 kDa as estimated by SDS-PAGE (Besse et al 2009, Gugerli 
et al 2009b, Rigotti et al 2006). This molecular weight is larger than the expected 
molecular weight calculated from the CP amino acid sequences of GLRaV-4 strains (circa 
30 kDa). However, such differences between theoretical molecular weight and SDS-
PAGE estimates are common (Rubinson et al 1997). MAb37a also reacted with the 
source AA42 (coinfected with GLRaV-7 and GLRaV-4 Ob), but not with the Pinot noir 23 
source (infected only by GLRaV-7) as demonstrated by Western blot (Fig. 4), ELISA (Fig. 
5), and IPEM (data not shown). These two GLRaV-7 isolates have been sequenced, and 
their coat proteins share high amino acid sequence homology (identity: 96.3%, similarity: 
99%) (Al Rwahnih et al 2012, Jelkmann et al 2012). Moreover, three additional 
accessions infected by GLRaV-7, but not by GLRaV-4 Ob, were also tested and they did 
not react with MAb37a. Therefore, common epitopes between GLRaV-4 Ob and GLRaV-
7 do not seem to exist and Mab37a should be considered to be specific to GLRaV-4 Ob 
and not to GLRaV-7, as stated previously. 
The GLRaV-4 Ob sequences determined in this study showed 93-98% identity with 
the previously reported GLRaV-4 Ru sequences at the amino acid level (Ito et al 2013). 
Furthermore, the serological relatedness between GLRaV-4 Ob and GLRaV-4 Ru was 
demonstrated in this study using MAb37a in DAS-ELISA (Fig. 5). GLRaV-4 Ob and the 
published partial sequences of GLRaV-4 Ru1 and 2 are 87 and 88% identical at the 
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nucleotide level, respectively. These two variants share a common epitope recognized by 
MAb37a; however, this epitope is not present in other GLRaV-4 strains because no cross-
reactivity was observed in DAS-ELISA against GLRaV-4, GLRaV-4 strain 5, GLRaV-4 
strain 6 and GLRaV-4 strain 9 (data not shown). 
The serological data were in agreement with the molecular data and strongly 
supported the conclusion of Ito et al. (2013) that GLRaV-4 Ob, is similar to variant GLRaV-
4 Ru, belongs to a distinct strain of the GLRaV-4 species. Furthermore, the amino acid 
identities between taxonomically relevant genes of GLRaV-4 Ob and other members of 
the GLRaV-4 species were between 68-78% (Table 2). The International Committee on 
Taxonomy of Viruses (ICTV) adopted an amino acid divergence threshold of 25% for 
RdRp, HSP70h and CP for the genus Ampelovirus (Thompson et al 2012), making 
GLRaV-4 Ob a highly divergent strain. Therefore, GLRaV-4 Ob should be considered a 
more diverse strain of the GLRaV-4 species. GLRaV-4 strain Car is another example of 
a more diverged member of GLRaV-4 cluster (Abou Ghanem-Sabanadzovic et al 2010).  
A number of studies have utilized different starting materials for deep sequencing, 
including purified viral particles (Melcher et al 2008), total RNA (Al Rwahnih et al 2009, 
Wylie and Jones 2011), small interfering RNAs (Kreuze et al 2009, Seguin et al 2014) 
and double-stranded RNAs (Al Rwahnih et al 2011, Al Rwahnih et al 2012, Coetzee et al 
2010). In this study, virus particles were first purified using ultracentrifugation before 
applying the deep sequencing techniques. This approach allowed us to obtain the 
complete genomic sequence of a closterovirus. The characterization of a new virus or 
strain is particularly tedious and laborious for woody crops due to low concentrations of 
the virus or due to the presence of inhibitors such as polyphenols that may interfere with 
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virus purification and/or nucleic acid amplification techniques (Candresse et al 2013). 
Furthermore, mixed infections and the extreme diversity of viruses infecting grapevines 
represent challenges for studying grapevine viruses. As previously reported (Al Rwahnih 
et al 2009, Giampetruzzi et al 2012, Studholme et al 2011, Wu et al 2010), the results 
presented here demonstrate the utility and value of applying deep sequencing technology 
to characterize new viral pathogens and to study viral disease aetiology. 
Serological and molecular data revealed that three grapevine accessions in our 
collection (Y276, Chiliaki Chjornyj, and AA42) are co-infected with GLRaV-4 Ob and 
GLRaV-7. Grapevines are prone to infection with several viruses and viral variants; thus, 
simultaneous infection by two or more viruses in the same grapevine plant is common (Al 
Rwahnih et al 2009, Goszczynski 2013, Hu et al 1990, Prosser et al 2007, Sharma et al 
2011). For example, Chasselas 8/22 is co-infected with GLRaV-2, GLRaV-4 strain 5, 
GLRaV-4 strain 6 and an unidentified virus with isometric morphology (Gugerli et al 1997, 
Poudel et al 2012). Previously, Chiliaki Chjornyj was reported to be co-infected with 
GLRaV-7 and GLRaV-4 Ru (Ito et al 2013). Importantly, for the first time, our molecular 
and serological examinations of grapevine accession AA42 revealed a mixed infection of 
two members of the family Closteroviridae, GLRaV-7 and GLRaV-4 Ob.  
GLRaV-7 was originally reported in a symptomless white-berried accession from 
Albania (AA42) that induced leafroll symptoms when grafted onto Cabernet Sauvignon 
indicators (Choueiri et al 1996). Because no other closteroviruses were identified in AA42, 
GLRaV-7 was considered the causal agent responsible for leafroll symptoms (Martelli et 
al 2012). However, different authors have reported that GLRaV-7 infections cause no or 
uncertain leafroll symptoms (Al Rwahnih et al 2012, Avgelis and Boscia 2001, Morales 
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and Monis 2007, Rowhani et al 2012). Our findings suggest that the leafroll symptoms 
from the AA42 isolate may not be related to GLRaV-7 infection as reported previously but 
is due to GLRaV-4 Ob. To the best of our knowledge, no case of GLRaV-7 infection 
associated with leafroll symptoms has been reported where co-infection with other 
closteroviruses can be completely excluded. Pinot noir 23 is the only grapevine accession 
in which GLRaV-7 Swi is present as a unique closterovirus (Al Rwahnih et al 2012), and 
this isolate does not induce any leafroll symptoms in Pinot noir and Cabernet sauvignon 
(Al Rwahnih et al 2012). Because GLRaV-7 cannot be conclusively associated with 
symptomatic infection, this virus may not be a leafroll-causing agent. Our findings support 
the proposition made by Al Rwahnhi et al. (2012) to replace the name “GLRaV-7”. 
Interestingly, a situation similar to leafroll disease and GLRaV-7 may exist in 
cherries, another long-lived vegetatively propagated plant species. Little cherry viruses 1 
and 2 are two species of the family Closteroviridae reported to be associated with little 
cherry disease (Jelkmann and Eastwell 2011). LChV-2 from the genus Ampelovirus 
induces typical little cherry disease symptoms in sweet and sour cherries (Jelkmann et al 
2008). In contrast, LChV-1, similar to GLRaV-7 belongs to the newly proposed genus 
Velarivirus; symptoms of LChV-1 infection are milder or absent because some isolates 
may not produce typical symptoms of little cherry disease (Katsiani et al 2014, Matic et al 
2009, Schröder and Petruschke 2010). 
In conclusion, this study describes a new virus that induces leafroll symptoms on 
cv. Gamay indicators. The serological and sequencing data reported here indicate that 
this virus belongs to subgroup II of the genus Ampelovirus. Therefore, we suggest the 
name Grapevine leafroll-associated virus 4 strain Ob (GLRaV-4 Ob) for this virus. This 
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work clearly demonstrates that two closteroviruses are co-infecting the AA42 grapevine, 
the accession from which GLRaV-7 was originally reported. The results presented here, 
together with previous reports of symptomless infection, suggest that GLRaV-7 is not 
associated with leafroll disease of grapevines. Future studies will be necessary to 
evaluate the phenotype of GLRaV-7 infections in grapevines definitively.  
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1. Abstract 
Background: The intestinal microbiome is a complex community and its role in influencing 
human health is poorly understood. While conventional microbiology commonly attributes 
digestive disorders to a single microorganism, a metagenomics approach can detect 
multiple pathogens simultaneously and might elucidate the role of microbial communities 
in the pathogenesis of intestinal diseases. We present a proof-of-concept that a shotgun 
metagenomics approach provides useful information on the diverse composition of 
intestinal pathogens and antimicrobial resistance profiles in human stool samples. 
Methods: In October 2012, we obtained stool specimens from patients with persistent 
diarrhoea in south Côte d’Ivoire. Four stool samples were purposefully selected and 
subjected to microscopy, multiplex polymerase chain reaction (PCR), and a 
metagenomics approach. For the latter, we employed the National Centre for 
Biotechnology Information nucleotide database and screened for 36 pathogenic 
organisms (bacteria, helminths, intestinal protozoa, and viruses) that may cause digestive 
disorders. We further characterized the bacterial population and the prevailing resistance 
patterns by comparing our metagenomics datasets with a genome-specific markers 
database and with a comprehensive antibiotic resistance database. 
Results: In the four patients, the metagenomics approach identified between eight and 11 
pathogen classes that potentially cause digestive disorders. For bacterial pathogens, the 
diagnostic agreement between multiplex PCR and metagenomics was high; yet, 
metagenomics diagnosed several bacteria not detected by multiplex PCR. In contrast, 
some of the helminth and intestinal protozoa infections detected by microscopy were 
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missed by metagenomics. The antimicrobial resistance analysis revealed the presence 
of genes conferring resistance to several commonly used antibiotics. 
Conclusions: A metagenomics approach provides detailed information on the presence 
and diversity of pathogenic organisms in human stool samples. Metagenomics studies 
allow for in-depth molecular characterization such as the antimicrobial resistance status, 
which may be useful to develop setting-specific treatment algorithms. While 
metagenomics approaches remain challenging, the benefits of gaining new insights into 
intestinal microbial communities call for a broader application in epidemiologic studies. 
2. Background 
An accurate diagnosis of diseases is crucial to identify the causative pathogen(s) giving 
rise to specific clinical syndromes, and is necessary for targeted treatment and 
personalized patient management (Khoury and Evans 2015, Pawlowski et al 2009). The 
interpretation of diagnostic test results can be straightforward when a specific pathogen 
is detected in a sample obtained from a normally sterile body compartment (e.g., synovial 
fluid in joint infections or cerebrospinal fluid in meningitis). However, diagnosis in 
specimens from the upper respiratory tract or the gastrointestinal tract remains 
challenging, as colonization with various microorganisms commonly occurs and their 
pathogenic potential and virulence may vary considerably (Frickmann et al 2015, Wessels 
et al 2014). 
Diarrheal diseases and related digestive disorders may be caused by more than 40 
different bacterial, parasitic, and viral pathogens (Becker et al 2013). A combination of 
several laboratory procedures has to be performed to cover the most common infectious 
agents with sufficient diagnostic accuracy (Knopp et al 2008). The epidemiology of the 
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causative pathogens is highly setting-specific, e.g., parasitic pathogens (helminths and 
intestinal protozoa) are much more common in tropical and subtropical areas, whereas 
bacteria prevail in industrialized countries (Fagundes-Neto 2013). However, quality data 
from tropical countries are scarce. In recent years, molecular diagnostic techniques, such 
as polymerase chain reaction (PCR) assays, have considerably improved the diagnostic 
yield of microbiologic stool examinations (Halligan et al 2014, McAuliffe et al 2013). In 
parallel, the application of these highly sensitive tools in clinical practice has brought to 
light that co-infection with several pathogens is the rule rather than the exception 
(Frickmann et al 2015, Steinmann et al 2010). Additionally, infectious agents that were 
previously thought to occur exclusively in symptomatic patients have been detected in 
healthy controls (Becker et al 2015b), which calls for the inclusion of asymptomatic 
controls in epidemiologic studies (Becker et al 2015a, Dubourg and Fenollar 2015). Taken 
together, these observations suggest that complex interactions between several intestinal 
pathogens and the ‘normal’ gut microflora rather than the presence of a single infectious 
agent may determine whether or not an individual develops clinical symptoms (e.g., 
diarrhoea) (Kinross et al 2011). However, little is known regarding the exact composition 
of the gut microbiome in patients and asymptomatic controls and its implications for 
human health. 
Conventional diagnostic methods for pathogen detection in human stool samples are 
relatively cheap and easy to use (e.g., stool microscopy for parasites and bacterial stool 
culture), but they are less sensitive than molecular assays (Zboromyrska et al 2014). As 
an alternative, commercially available molecular assays such as the Luminex 
Gastrointestinal Pathogen Panel (GPP) (Wessels et al 2014) for the detection of a broad 
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range of pathogens have been developed. However, flexibility and adaptation of these 
assays with regard to genetic variation and new pathogens remain difficult. The 
emergence of new technologies, such as next-generation sequencing, as well as parallel 
optimization of bioinformatics software bring about opportunities in the field of infectious 
disease diagnostics. The rapidly growing field of metagenomics already provided new 
insights into the gut microflora (Human Microbiome Project 2012, Karlsson et al 2013, 
Sun and Relman 2013) and has deepened our understanding of the importance and links 
of intestinal micro-organisms (De Filippo et al 2010, Proal et al 2011, Scher et al 2013) 
with various health conditions. Metagenomics is a combination of research methodologies 
aimed at characterizing complex microbial communities without isolating or culturing 
organisms (Handelsman 2004). It is a powerful tool to study the complete range of 
pathogenic organisms, the so-called pathobiome, and thus generates highly valuable 
baseline information on rare pathogens, unculturable bacteria and multiple infections, 
which are common in low- and middle-income countries (Phan et al 2014, Steinmann et 
al 2010). Another important application of a metagenomics approach is its potential to 
analyse sequence datasets with several databases, thereby allowing for a distinct 
characterization of pathogens and antimicrobial resistance genes. Hence, this approach 
can provide specific health-relevant information on the patient and may guide the clinician 
toward personalized health care. 
Here, we present a proof-of-concept study using a metagenomics approach to 
investigate the composition of the intestinal bacterial, parasitic, and viral flora in stool 
samples obtained from patients with persistent diarrhoea in Côte d’Ivoire. Additionally, 
the metagenomics data were compared to conventional diagnostic techniques and 
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multiplex PCR. Practical aspects of metagenomics in the field of medical diagnostics and 
public health are discussed. 
3. Methods 
a. Ethics statement 
The stool samples analysed here were obtained during a study on persistent diarrhoea in 
southern Côte d’Ivoire (Becker et al 2015b). The study protocol was approved by the 
institutional research commissions of the Swiss Tropical and Public Health Institute 
(Swiss TPH; Basel, Switzerland) and the Centre Suisse de Recherches Scientifiques en 
Côte d’Ivoire (CSRS; Abidjan, Côte d’Ivoire). The study was cleared by the Directorate of 
the Hôpital Méthodiste in Dabou. The study is registered on Current Controlled Trials 
(http://www.controlled-trials.com; identifier ISRCTN86951400). All participants were 
informed in detail about the aims and procedures of the study and written informed 
consent was obtained before stool collection and any laboratory investigation. 
b. Study area and population 
The study was conducted in October 2012 in Dabou and surrounding villages, located 
some 30 km west of Abidjan, the economic capital of Côte d’Ivoire. The study was 
embedded in a preliminary investigation to identify a suitable setting for a subsequent 
multi-country study on the aetiology of persistent diarrhoea (≥2 weeks) and persistent 
abdominal pain (≥2 weeks) in resource-constrained settings of Africa and Asia (Becker et 
al 2015b, Polman et al 2015). 
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c. Field and laboratory procedures 
Details of the study area, inclusion criteria, patients and asymptomatic controls, and 
clinical and laboratory procedures have been described elsewhere (Becker et al 2015b). 
In brief, fresh stool samples from individuals with persistent diarrhoea as defined by the 
World Health Organization (WHO; ≥3 loose stools per day for ≥2 weeks) were obtained 
and a short clinical questionnaire was administered. The stool samples were processed 
at the laboratory of the Hôpital Méthodiste in Dabou, using the following suite of laboratory 
examinations for parasite diagnosis: (i) Kato-Katz technique for Schistosoma mansoni 
and soil-transmitted helminths (Ascaris lumbricoides, hookworm, and Trichuris trichiura); 
(ii) Baermann funnel concentration for Strongyloides stercoralis and hookworm; (iii) Koga 
agar plate for S. stercoralis and hookworm; and (iv) formalin-ether concentration 
technique applied to fixed stool samples for helminths and intestinal protozoa. 
Additionally, rapid diagnostic tests (RDTs) were used for the detection of Clostridium 
difficile (synonymous: Peptoclostridium difficile), Cryptosporidium spp., and Giardia 
intestinalis. Small aliquots of stool samples were transferred at ambient temperature to a 
reference laboratory in Europe (Institute of Medical Microbiology and Hygiene; Homburg, 
Germany) for post-hoc molecular diagnosis using the Luminex GPP multiplex PCR 
(Becker et al 2015b). Upon arrival in the reference laboratory, samples were stored 
at -20°C pending further examination. For the current study, four purposefully selected 
stool aliquots were sent to Spiez Laboratory (Spiez, Switzerland) for in-depth analysis 
using shotgun metagenomics. 
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d. Preparation of nucleic acids 
From each of the four stool samples, 150 mg were taken to extract nucleic acids in 50 μl 
nuclease-free water using an Isolate Faecal DNA Kit (Bioline; London, UK), following the 
manufacturer’s instructions. Concentrations were measured on a Qubit 2.0 fluorometer 
(Life Technologies; Darmstadt, Germany) using the dsDNA high-sensitivity assay. 
e. Sequencing and data availability 
Data libraries were prepared with 10 μl of each sample using Nextera XT library kits 
(Illumina; San Diego, USA) and the MiSeq platform (Illumina; San Diego, USA) was used 
to sequence the libraries in 2×250 base pairs (bp) paired-end mode. An in-house 
developed Perl pipeline was used to process the sequence datasets. The pipeline 
consists of three main steps: (i) pre-processing and curation of the datasets; (ii) assembly 
of the curated sequences; and (iii) comparison of the assembled sequences to various 
databases. 
Pre-processing was further sub-divided in three steps; namely (i) quality control; (ii) 
filtering of human sequences; and (iii) assembly of the datasets. The tool FastQC 
(Andrews 2010) version 10.1 was used to generate quality reports. The suite ea-utils 
(Aronesty 2011) version 1.1.2 was used to remove reads not passing the proprietary 
CASAVA filter of Illumina. The same software was employed to remove bases with a 
quality score below Q20 both at the 5’ and 3’ ends. Using Bowtie 2 version 2.2.3 
(Langmead and Salzberg 2012) against Homo sapiens reference genomes allowed to 
filter and remove human-related sequences. Of note, no sequences pertaining to the 
human genome were analysed during this study. 
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The remaining reads were assembled using MIRA (Chevreux et al 1999) version 
4.0.2 on an Ubuntu-based 24 cores and 256 GB RAM workstation. MIRA was used in “de 
novo” and “accurate” mode with four assembly passes (nop = 4). 
f. Databases employed for metagenomics 
Three databases were used to characterize the four stool samples: (i) National Centre for 
Biotechnology Information nucleotide (NCBI nt); (ii) genome-specific markers (GSMer); 
and (iii) comprehensive antibiotic resistance database (CARD; McArthur et al., 2013). Key 
features of the three databases are summarized in Table 1. Sequences were compared 
to these databases using the basic local alignment search tool (Camacho et al 2009) 
version 2.2.28 configured with database-specific parameters. 
The NCBI nt database (Benson et al 2013) is the largest sequence repository and is 
widely used for genomic sequences analyses. We employed NCBI nt database to screen 
for pathogenic parasites, viruses, and bacteria focusing on 36 sequenced organisms that 
may give rise to persistent digestive disorders (Becker et al 2013). Due to high 
redundancy of sequences between closely related organisms in the NCBI nt database, 
taxonomic results, including identified strains, serovars, and pathovars, were discarded 
in order to ensure that only highly significant results were kept. Moreover, BLASTn 
parameters were kept rather stringent with four BLAST steps with decreasing wordsizes 
(300, 150, 100, and 50) and an E-value cut-off of 10-5. 
The recently published GSMer database (Tu et al 2014) was utilized to screen for 
bacterial strains with a high accuracy. Briefly, GSMer database contains strain-specific 
markers that were selected using a novel k-mer-based approach. It contains over 2 million 
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50-mers markers for 5,418 bacterial strains. For the screening against this database, the 
filtered reads were used and the BLAST analysis was performed using a wordsize of 50. 
The CARD (McArthur et al 2013) is a curated and well-maintained database 
containing sequences of antimicrobial resistance genes. The CARD was added to 
investigate whether a metagenomics approach might also be suitable for identification of 
additional health-relevant molecular characteristics, such as genes that may confer 
resistance to antibiotics. 
The BLAST algorithm was used with the same parameters as for the screening 
against NCBI’s GenBank database. Results from the three BLAST searches were 
analysed in a sample-specific report file using the BioPerl toolkit (Stajich et al 2002). The 
complete taxonomic information for each BLAST hit was retrieved using the NCBI 
taxonomy identifier (taxid). 
4. Results 
a. Data analysis and patient characteristics 
The conceptual framework of the analysis pipeline employed in the current study is shown 
in Figure 1. All four patients (A-D) whose faecal samples were subjected to a 
metagenomics approach had persistent diarrhoea. Additionally, three of these individuals 
concurrently complained of persistent abdominal pain. Of note, one participant was 
infected with the human immune deficiency virus (HIV). Table 2 summarizes patient 
characteristics. 
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b. Identified organisms according to different diagnostic approaches 
Each metagenomics dataset was screened against 36 pathogens, including 
diarrheagenic bacteria, helminths, intestinal protozoa, and DNA viruses (Table 3). The 
key findings from this metagenomics approach, in comparison to conventional stool 
microscopy, RDTs, and multiplex PCR, are summarized in Table 4. In brief, using 
shotgun metagenomics, we identified between eight and 11 potential pathogen classes 
in the four patients. Some pathogens, including Aeromonas caviae, Escherichia coli 
(represented by 7, 1, 6 and 32 different strains, respectively), Campylobacter spp., and 
microsporidia were found in all four samples. Vibrio parahaemolyticus was only found in 
sample A. One C. difficile strain was observed in samples A and B. Traces of Salmonella 
enterica and Shigella spp. were detected in samples A, C, and D. Entamoeba histolytica 
was found in samples B and D. Mycobacterium abscessus was detected in sample D. 
One Vibrio cholerae strain and Yersinia spp. were found in samples B and D, respectively. 
Sequences belonging to the nematode A. lumbricoides and the trematode S. mansoni 
were found in sample B. 
None of the target organisms were identified in sample A, using standard diagnostic 
tools (microscopy and RDTs) and multiplex PCR. Using microscopy, Entamoeba coli was 
found in samples B and C. In addition, A. lumbricoides, Chilomastix mesnili, and 
G. intestinalis were found in sample B, whilst B. hominis was detected in sample C. Use 
of the dual-strip RDT to concurrently test for G. intestinalis and Cryptosporidium spp. 
revealed a positive reaction in sample B for G. intestinalis and for Cryptosporidium spp. 
in sample D. The presence of G. intestinalis and Cryptosporidium spp. in samples B and 
D, respectively, was confirmed using multiplex PCR. 
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c. Performance of metagenomics approach 
A total of 431, 691, 3,967, and 1,056 million bases (MB) were generated for samples A, 
B, C, and D, respectively. The percentage of reads with more than 70% of bases with a 
Phred quality score over Q20 was 82% for sample A, 86% for sample B, 72% for sample 
C, and 78% for sample D. While it took between 171 and 464 min for three of the samples 
to assemble, sample D was running for 6,406 min for a complete assembly on a 48 cores 
machine using the MIRA assembler. Figure 2 shows the quality of assembly for the four 
samples. 
Subsamples of randomly selected reads among the dataset for sample C were 
selected in order to assess the detection rate of the different parameters with various 
amounts of reads. Five subsamples with 1.1, 3.3, 5.5, 7.7, and 9.9 million reads randomly 
selected from the initial 11 million reads of sample C were generated. Figure 3 
summarizes the number of unique taxonomic IDs, unique antimicrobial resistance genes, 
and several pathogenic classes found in the different subsamples. 
Number of taxonomic IDs identified in the different subsamples started at 309 in 
subsample 1 and reached 921 of identified taxonomic IDs for the complete sample. For 
the pathogenic classes, the range spanned from five identified pathogenic classes for 
subsample 1 to 10 identified pathogenic classes for the full sample. Finally, regarding the 
number of unique antimicrobial resistance genes, it ranged from 33 identified genes for 
subsample 1 and 68 identified genes for the complete sample. The number of assembled 
contigs ranged from 22,233 up to 66,341, while the percentage of hits against the NCBI 
nt and CARD databases ranged from 56.31% to 90.98% and from 0.23% to 3.52%, 
respectively. 
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d. Antimicrobial resistance analysis 
Aiming to identify other important health-related aspects, the samples were screened for 
a host of antimicrobial resistance genes, using CARD. Figure 4 summarizes the potential 
antibiotic resistances based on the detection of the corresponding antimicrobial 
resistance genes. 
Resistance genes for four antibiotics from two different antibiotic classes were 
observed in sample A. For sample B, genes were found for 14 antibiotics from six classes, 
including the recently introduced glycylcycline class (i.e., tigecycline). Patient C provided 
a sample where eight different antibiotics resistances from five classes were found. In 
sample D, genes that could potentially provide resistance to 25 different healthcare-
relevant antibiotics from eight classes were detected. 
5. Discussion 
We present a proof-of-concept using a novel metagenomics approach for the diagnosis 
of a wide range of pathogens that may give rise to persistent digestive disorders. We 
purposefully selected four stool samples from well-characterized patients with persistent 
digestive disorders who presented to the hospital of Dabou, south Côte d’Ivoire. Sample 
A was provided by a 1-year-old female with persistent diarrhoea (≥2 weeks). Using all the 
aforementioned diagnostics methods, including multiplex PCR techniques, did not help 
to diagnose the cause of the clinical symptoms. The metagenomics approach enabled 
the identification of various pathogenic organisms that could potentially have caused the 
symptoms. Samples B and C were obtained from children (aged 5 and 12 years), one 
living in a rural and the other in an urban setting. These two samples were selected 
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because persistent diarrhoea in this age group is more likely to be caused by an infection, 
whereas other non-communicable aetiologies occur more often in older age groups. The 
fourth sample stemmed from a 34-year old female, HIV-infected patient. This sample was 
included to determine whether the spectrum of detected pathogens and resistance genes 
would differ significantly between an immunocompromised patient and other individuals 
from the same setting. Due to the immunocompromised state of this patient, it is 
conceivable that the individual may have experienced multiple previous infections (e.g., 
pneumonia and infective gastroenteritis). Because of the scope of this study, placing 
particular emphasis on diagnostic agreement rate between standard diagnostic tools 
(including microscopy and RDTs), a validated molecular tool (Luminex xTAG), and an 
experimental molecular tool (metagenomics), we did not include stool samples from 
asymptomatic controls. We believe that the results of the metagenomics analysis of a 
non-related stool sample would have limited outcomes since the microbiome itself is 
highly diverse and specific to an individual. The stool samples were examined with a suite 
of diagnostic techniques (i.e., microscopy, RDTs, and multiplex PCR), and subsequently 
subjected to a novel metagenomics approach. With regard to helminth diagnosis, our 
metagenomics approach holds promise. While A. lumbricoides was detected in sample B 
both by classical microscopy and metagenomics, S. mansoni was detected in sample B, 
but only with metagenomics. Of note, the full genome sequence of S. mansoni has been 
published in 2009 (Berriman et al 2009). Our findings suggest that metagenomics, 
provided that complete sequence data are available, has a higher detection capacity than 
currently more widely used methods, most importantly stool microscopy (Utzinger et al., 
2015). 
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For intestinal protozoa, particularly Cryptosporidium spp., G. intestinalis, and 
Entamoeba coli, conventional diagnostic techniques were superior compared to our 
metagenomics approach. Indeed, metagenomics failed to detect these pathogens, while 
they were diagnosed with standard microscopy. On the other hand, our metagenomics 
approach proved useful for bacterial diagnosis and allowed retrieval of detailed taxonomic 
information. In comparison to other diagnostic techniques, which usually require a series 
of specific tests for the detection of various pathogens that may give rise to a clinical 
syndrome (e.g., various selective agar plate media for enteropathogenic bacteria), 
metagenomics can – in a single sequencing run – identify an extensive range of human 
health-relevant bacterial pathogens down to the strain level. Indeed, a very large number 
of bacterial genomes are well assembled and annotated. Possibly explained by the higher 
complexity, thus far, only a limited number of eukaryotic genomes have been completely 
assembled and annotated. While this represents a shortcoming for metagenomics, 
numerous projects aim at providing improved genomic data for higher organisms. In view 
of these developments, we speculate that diagnosis of intestinal protozoa using a 
metagenomics approach will become feasible in the not too distant future. 
In order to standardize and further improve the diagnostic yield of a metagenomics 
approach, the establishment of complete syndrome-specific lists (e.g., persistent 
digestive disorders, persistent fevers, and persistent neurological disorders) (Becker et al 
2013, Yansouni et al 2012, Yansouni et al 2013) as well as the establishment of the 
corresponding sequence databases would facilitate such analyses and would further 
reduce the required time to perform these in-depth diagnostics. Additionally, such 
syndrome-specific databases might allow the generation of pathogen-symptoms profiles 
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that could be compared between patients affected with the same syndrome, but with 
different profiles of signs and symptoms. Thereby, variations in the symptomatology could 
potentially be linked with the presence of multiple pathogens and would provide new 
insights into the complex interactions between multiple enteric pathogens, the intestinal 
microbiome, and arising clinical signs and symptoms (Kinross et al 2011). In particular, 
the impact and combined effects of multiple infections could be studied, which is of critical 
importance, as co-infections are the norm rather than the exception in many tropical 
settings (Raso et al 2004, Steinmann et al 2008, Steinmann et al 2010). Further potential 
benefits at the population-level could be the establishment of comprehensive databases 
that provide setting-specific information on prevailing antibiotic resistance mechanisms 
and could thus guide the adaptation and development of context-sensitive guidelines for 
empiric anti-infective treatment of common clinical syndromes. For individual patient 
management, metagenomics data might be used to provide personalized treatment, e.g., 
following the rapid identification of causative pathogens and their antimicrobial resistance 
profile. For example, we could find an elevated number of antibiotic resistance genes in 
sample D, which might be explained by previous anti-infective treatments, which in turn 
would guide personalized intervention. Such highly targeted treatments may even help to 
monitor and prevent the spread of antibiotic resistance development. 
Nevertheless, our study has several limitations. First, the application of 
metagenomics on only four samples – all selected purposefully – does not allow drawing 
inference that could be more widely extrapolated. However, we conducted this study as 
a proof-of-concept and found that metagenomics indeed provides highly relevant data on 
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the composition of the intestinal flora and other health-related factors that may improve 
our understanding of the aetiology and pathogenesis of diarrheal diseases. 
Second, while metagenomics provides highly accurate data, it requires the use of 
next-generation sequencing techniques, which are currently too expensive to be applied 
in resource-constrained settings and many diagnostic centres also in industrialized 
countries. The combined costs of microscopy, including Kato-Katz thick smear (US$ 2 
per sample) and FLOTAC (US$ 2.5 per sample), RDTs (approximately US$ 4 per 
sample), and multiplex Luminex GPP (~US$ 80 per test) approached US$ 100 per sample 
in this study. Compared to a single sequencing experiment, which now costs 
approximately US$ 250, it is still a factor 2-3 more expensive and therefore not yet 
applicable in most contexts. It should be kept in mind, however that metagenomics 
provides significantly more health-relevant information and if optimized and further 
standardized, it might become the method of choice as it allows multiple pathogen 
identification at once. 
Third, we cannot exclude that the quality of extracted nucleic acids has been 
negatively affected by the interruption of the cold chain from the collection of stool 
samples in the hospital in Dabou until final analysis in a European laboratory (Becker et 
al., 2015c). Hence, some information may have been lost. 
Fourth, the application of further diagnostic techniques such as RNA-based meta-
transcriptomics analyses would have further increased the diagnostic yield, i.e., by 
obtaining even more information on the current status of infections, co-infections, 
‘pathogenic synergies’, infections with RNA viruses as well as phenotypically expressed 
antibiotic resistance patterns. 
 122 
 
Fifth, our metagenomics approach is directly linked to resistance mechanisms of 
various pathogen species. The fact is that resistances might be acquired by different 
mechanisms, including horizontal DNA transfer (e.g., plasmids), and hence, they might 
result from a single point mutation in a gene or the resistance itself might be directly linked 
to the expression level of the corresponding gene. While a metagenomics approach 
allows to draw a general picture of the resistome, it might require some additional 
improvements (e.g., RNA-sequencing), to be able to link antimicrobial resistances to a 
specific bacterial strain. 
In conclusion, we provide a proof-of-concept that a metagenomic approach is a 
powerful diagnostic tool that holds promise to deepen our understanding of infectious 
diseases and their pathogenesis. A large variety of pathogens could be diagnosed in 
clinical samples that remained undetected despite the use of a suite of sensitive 
diagnostic assays, including commercially available multiplex PCR assays. The 
diagnostic accuracy of metagenomics was high for a wide range of bacteria, but less so 
for the detection of parasitic pathogens, which can be explained by the current 
unavailability of sequence data for many human parasites. Hence, before wider 
application, metagenomics need further improvements pertaining to the duration of 
sample analysis, the high costs associated with sequencing, database content and 
quality, and additional tools for sequence comparison need to become available. 
However, it is conceivable that the insights gained from in-depth diagnostic studies 
employing metagenomics will considerably enhance the etiologic understanding, 
diagnosis, and management of diarrheal diseases and potentially other important clinical 
syndromes on local, regional, and global scales. 
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Table 1. Key features of the three databases employed during a proof-of-concept 
metagenomics approach for the diagnosis of multiple pathogens in human stool samples 
in Dabou, south Côte d’Ivoire in October 2012. bp, base-pair; CARD, Comprehensive 
Antimicrobial Resistance Database; GSMer, Genome-Specific Markers database; N.A., 
Not available; NCBI nt; National Centre for Biotechnology Information nucleotide 
database. 
Database Sequence type Number of 
sequences 
Organism spectrum Sequence 
size (bp) 
NCBI nt Publicly available 
sequences 
182,188,746 Any sequenced 
organisms 
N.A. 
GSMer Bacterial strain-specific 
markers 
>2,000,000 5,418 bacterial 
strains 
50 bp 
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CARD Antibiotic resistance genes 2,993 All bacteria N.A. 
 
Table 2. Epidemiological and clinical characteristics of four patients with persistent 
diarrhoea in Dabou, south Côte d’Ivoire, in October 2012. 
Characteristics Sample A Sample B Sample C Sample D 
Residency Dabou (town) Rural village Dabou (town) Dabou (town) 
Sex Female Male Male Female 
Age (years) 1 5 12 34 
Signs and 
symptoms 
Persistent 
diarrhoea, 
nausea, vomiting 
Persistent 
diarrhoea, 
abdominal pain 
Persistent 
diarrhoea, 
abdominal pain 
Persistent 
diarrhoea, 
abdominal pain, 
weight loss 
Previous anti-
infective 
treatment 
No No No Yes (unknown) 
Comorbidity None None None HIV infection 
 
 
Table 3. Summary of 36 pathogens, including bacteria, intestinal protozoa, helminths 
and viruses screened using the metagenomics approach. 
Bacteria Helminths 
Aeromonas spp.; Campylobacter spp.; 
Clostridium difficile; Escherichia coli; 
Mycobacterium spp.; Plesiomonas 
shigelloides; Salmonella spp.; Shigella spp.; 
Tropheryma whipplei; Vibrio spp.; Yersinia 
spp. 
Ancylostoma duodenale; Ascaris 
lumbricoides; Capillaria spp.; Digenea 
(intestinal flukes); Diphyllobotrhium latum; 
Hymenolepsis spp.; Necator americanus; 
Schistosoma spp.; Strongyloides spp.; 
Taenia spp.; Trichuris trichuria  
Intestinal protozoa Viruses 
Chilomastix mesneli; Cryptosporidium spp.; 
Cyclospora cayetanensis; Cystoisospora 
belli; Dientamoeba fragilis; Entamoeba spp.; 
Giardia intestinalis; Microsporidia; Naegleria 
fowleri; Neobalantidium coli; Toxoplasma 
gondii 
Adenoviridae; Bocavirus; Cytomegalovirus 
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Table 4. Comparison of conventional parasitology, rapid diagnostic tests (RDTs), a 
commercial Luminex multiplex PCR and a metagenomics approach for detection of 
intestinal pathogens in four human stool specimens obtained in Dabou, Côte d’Ivoire, in 
October 2012. 
 
Organism list 
Conventional 
parasitology 
Rapid 
diagnostic 
tests 
Luminex 
GPP 
Metagenomics 
% DNA in 
total 
microbiome 
Sample 
A  
Aeromonas spp.       
A. caviae (1 
strain) 0,006 
Peptoclostridium difficile       1 strain 0,034 
Campylobacter spp.       Positive 0,004 
Escherichia coli       7 strains 0,091 
Microsporidia spp.       Positive 0,010 
Salmonella spp.       1 strain 0,013 
Shigella spp.       Positive 0,038 
Vibrio parahaemolyticus       Positive 0,053 
Sample 
B  
Ascaris lumbricoides Positive     Positive 0,013 
Aeromonas spp.       
A. caviae (1 
strain) 0,010 
Peptoclostridium difficile       1 strain 3,485 
Campylobacter spp.     Positive C. jejuni (1 strain) 0,044 
Chilomastix mesnili Positive         
Entamoeba spp. E. coli     E. histolytica 0,032 
Escherichia coli       1 strain 0,012 
Giardia intestinalis Positive Positive Positive     
Mycobacterium abscessus       Positive 0,002 
Microsporidia spp.       Positive 0,004 
Schistosoma mansoni       Positive 0,118 
Shigella spp.     Positive Positive 0,001 
Vibrio spp.       
V. cholerae (1 
strain) 0,026 
Yersinia spp.       Positive 0,006 
Sample 
C  
Aeromonas spp.       
A. caviae (1 
strain) 0,157 
Blastocystis spp. B. hominis         
Campylobacter spp.       Positive 0,002 
Escherichia coli     ETEC 6 strains 0,054 
Entamoeba spp. E. coli     E. histolytica 0,002 
Giardia intestinalis     Positive Positive 0,001 
Microsporidia spp.       Positive 0,002 
Mycobacterium abscessus       Positive 0,041 
Norovirus GI/GII     Positive     
Salmonella spp.       Positive 0,248 
Shigella spp.       Positive 0,017 
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Sample 
D  
Aeromonas spp.       
A. caviae (1 
strain) 0,008 
Campylobacter spp.       Positive 0,001 
Cryptosporidium spp.   Positive Positive     
Escherichia coli     ETEC 32 strains 2,997 
Mycobacterium abscessus       Positive 0,003 
Microsporidia spp.       Positive 0,001 
Salmonella spp.     Positive 3 strains 0,098 
Shigella spp.       1 strain 0,127 
Vibrio cholerae       1 strain 0,005 
Yersinia spp.       Positive 0,001 
 
Figure captions 
Figure 1. Bioinformatics pipeline used to retrieve information relevant to the patients’ 
health from the metagenomics datasets. This graph summarizes the steps required for 
processing raw sequencing reads until the comparison of the prepared reads against 
three different databases. 
 
Figure 2. Comparison of shotgun assembly metrics between four human stool samples 
that were provided by patients with persistent diarrhoea in Dabou, south Côte d’Ivoire, in 
October 2012. The values are summarized in stacked histograms showing the proportion 
of each parameter from each sample compared to the rest of the samples 
 
Figure 3. Assembly comparison of sub-samples of one patient with persistent diarrhoea 
(sample C) in Dabou, south Côte d’Ivoire in October 2012. (A) Observed abundance of 
taxonomic IDs, antimicrobial resistance genes and pathogenic classes from randomly 
selected subsamples of sample C. (B) Number of assembled contigs from the same 
subsamples of sample C and the percentage having a BLASTn hit against the NCBI 
nucleotide database and the comprehensive antibiotic resistance database. 
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Figure 4. Resistome of four diarrheic human stool samples in Dabou, south Côte d’Ivoire, 
in October 2012. The detected antibiotic resistance genes in the stool specimens are 
indicated by black bars. 
Figure 1. 
 
Figure 2.
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1. Abstract 
Background: Kampala, the capital city of Uganda, is rapidly growing with annual 
population growth rate of up to 5.6%. Combined with unplanned urbanization, this is 
leading to a lack in wastewater treatment infrastructures for most of the 1.8 million 
inhabitants. Consequently, it is plausible that water streams and natural ecosystems 
around the city are heavily polluted, both with organic and inorganic contamination. 
However, specific data on pathogenic microorganisms, which are potentially arising 
health threats for the population, remain scarce. Hence, we performed an in-depth 
analysis using a metagenomics approach to characterize the Nakivubo system including 
its wastewater channel, the surroundings wetlands, and, to some extent, the inner 
Murchison bay. 
Methods: In October 2013, we obtained water samples from 23 locations distributed 
homogeneously within three ecosystems: the Nakivubo channel itself, the wetland areas 
located around it, as well as four samples collected at the Murchison bay, on Lake 
Victoria. The samples were concentrated on-site using tangential flow filtration and 
transferred to Switzerland, where they were sequenced using Illumina’s technology. A 
total of 1.2 billion sequencing reads were generated and compared either after quality 
filtering to a bacterial strain-specific database (GSMer), or after de novo assembly to the 
NCBI nt database. 
Results: Based on the composition of the bacterial communities in the water samples, 
three clearly differentiated clusters could be identified with regards to their microbial 
diversity. A high correlation between Escherichia coli intra-species diversity and the total 
bacterial strains was identified. Using linear regression analyses, it was possible to find 
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strong correlation of the taxonomic composition with distance of several non-channel 
samples with their closest channel samples, allowing us to highlight potential leakage 
points of the Nakivubo channel. The three environmental clusters harbour several 
significant differences in their respective microbial structure. Several pathogenic 
microorganisms could be strongly correlated with wastewater contamination across the 
system.  
Conclusion: This study is an example of the power of metagenomics approaches to 
perform system wide-characterization of the environment. To our knowledge, it is the first 
of its kind, attempting to characterize the main wastewater system in a booming African 
megapolis and trying to find the potentially related health hazards for the human 
populations. We were able to make important statements concerning the system including 
i) that it has a sub-optimal wastewater treatment capacity, ii) that containment potential 
of the wastewater isn’t sufficient, iii) highlight the potential leakage points, and iv) to 
pinpoint potential risks for human health arising from contamination of the environment 
by wastewater.  
2. Introduction 
Kampala is the capital city of Uganda and is located on the northern shores of Lake 
Victoria, at an altitude of 1140 m above sea level. The climate in Kampala is tropical with 
precipitations throughout the year, mainly concentrated during two rainy seasons, the first 
one occurring between March and May and the second one from October to November. 
With an annual population growth of 5,6% and a population of more than 1.5 million 
inhabitants in 2014, it is among the fastest growing cities in sub-Saharan Africa (Statistics 
2001, Vermeiren et al 2012). Despite its fast demographic and overall economic 
 139 
 
development, arising social and health-related challenges have not yet been fully 
addressed, as can be seen e.g. in the relatively moderate increase of funding in the field 
of water supply (Okuonzi 2004). Considerable population growth in combination with rapid 
urbanization are putting pressure on existing wastewater infrastructures. Indeed, only 
approximately 10% of Kampala’s total population is connected to a sewer, while the large 
majority is relying on on-site sanitation systems such as pit latrines and septic tanks 
(Fuhrimann et al 2014, Fuhrimann et al 2015, Kansiime and Maimuna 1999). Moreover, 
industrial development and urban farming have led to a reduction of wetland systems 
around the city that have previously served as natural wastewater treatment resources 
(Fuhrimann et al 2015, Kansiime and Maimuna 1999, Mbabazi et al 2010). With a surface 
of 5.29 km2 and a total catchment area of over 40 km2 (Emerton et al 1999), the Nakivubo 
wetland is the largest of a series of 12 wetland areas surrounding the city of Kampala. It 
is divided by an old railway line, with the area located north of the railway being composed 
mainly of drained wetland and the area located south of it composed mainly of floating 
wetlands. The Nakivubo wetland also serves as an agricultural ground, with yams and 
sugar cane being the main cultivated crops. As farmers directly re-use wastewater for 
irrigation purposes, any health threats present in the water will impact on the farmers’ 
health and the safety of agricultural products grown in this area. The Nakivubo wetland 
area is also subjected to flooding events, especially during the rainy season, and this puts 
an estimated 12’000 individuals living in the surrounding slums at risk of direct contact 
with wastewater (Kayima et al 2008, Mbabazi et al 2010). Several studies elucidated the 
potential risk of exposure to waste water on human health (Al-Jassim et al 2015, Becerra-
Castro et al 2015, Lu et al 2015, Youenou et al 2016). The World Health Organization 
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(WHO) recommends to assess and quantify standard indicators of water faecal 
contamination, e.g. by microbiological analysis of the number of faecal bacteria in water 
samples (WHO 2011). A recent study by Fuhrimann et al. (2015) reported that the counts 
of colony-forming units (CFUs) of both Escherichia coli and Salmonella spp. along the 
main wastewater treatment system in Kampala, including the Nakivubo channel and 
wetlands, were above the thresholds set by WHO for unrestricted use for irrigation in 
agriculture (WHO 2011). However, detailed phylogenetic and microbiological information 
on the exact composition of pathogenic organisms is scarce in Kampala and other rapidly 
growing urban areas in sub-Saharan Africa (Bateganya et al 2015, Youenou et al 2016).  
Hence, we employed a shotgun metagenomics approach on a set of water samples 
collected along the Nakivubo channel to characterise the microbiological composition of 
this dynamic environment and to further assess potentially arising health consequences 
for the exposed population.  
The overarching aim of this study was to use an advanced molecular approach in 
a resource-constraint setting, namely, metagenomics, to provide an in-depth 
representation of the effective microbial contamination, and potentially human-health 
specific risks, along the main wastewater treatment network in the city of Kampala. We 
aimed at providing a system-wide analysis of the Nakivubo system by, i) grouping 
samples with regards to their microbial profiles, ii) characterizing each group’s 
specificities and iii) focusing our analysis on the distribution of bacterial, eukaryotic, viral 
and fungal pathogens and their relations with wastewater contamination, in this specific 
context. 
3. Methods 
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a. Sampling strategy 
In the frame of this study, a total of 23 water samples were collected at different locations 
distributed all along the wastewater collection network of Kampala city, as shown in 
Figure 1. The samples were collected within one day, to provide a comparable snapshot 
of the bacterial communities. Sample collection was performed in a relatively dry period 
in October 2013. 
 
 
Figure 1. Map of the study area, including Kampala city, the Nakivubo wetland area and 
the inner Murchison Bay (Lake Victoria). This map shows the sampling locations of the 
22 water samples. Samples collected on the channel are coded with C (1-5), samples 
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collected in the wetlands are coded with W (1-14) and samples collected on Lake Victoria 
are coded with L (1-4).  
The 23 samples were labelled belonging to one of the three ecosystems we 
planned to study, namely, (i) the Nakivubo wastewater channel (Samples C1 to C5); (ii) 
the Nakivubo wetlands (Samples W1-W14); and (iii) the inner Murchison bay of Lake 
Victoria (Samples L1-L4). Two samples from the W series (Samples W13 and W14) were 
collected directly at informal communities’ outlets flowing directly into the wetlands. One 
sample from the L series (L3) was collected directly at the city’s freshwater intake, located 
in Gaba, approximately 5.8 kilometres south from the Nakivubo channel outlet. Sample 
L4, located in the middle of the Murchison Bay, approximately 8.2 kilometres south from 
the Nakivubo outlet, serves as a low human-related contamination control. Of note, one 
tube, which contained sample W5 broke during transportation, therefore this sample could 
not be analysed and no results on this specimen can be reported. Hence, 22 samples 
were used for the final analysis. 
b. Sample collection procedure, storage and nucleic acid extraction.  
At each location, a minimum of one litre of surface water was collected. Upon arrival in 
the local laboratory, the samples were directly stored in a fridge at a temperature of 4°C. 
Each sample was then concentrated using a tangential flow filtration unit into a smaller 
volume of approximately 50 ml. The concentrated samples were frozen at -20°C and 
transferred to Switzerland in a cooling box to avoid microbial growth. Upon arrival in 
Switzerland, the 50 ml samples were further concentrated with Amicon® Ultra Centrifugal 
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Filter Units with a molecular cut off of 10K Daltons (Millipore; Billerica, MA, United States 
of America) into a smaller volume of approximately 150 µl. 
Nucleic acids were isolated from 150 µl of the concentrated samples using a 
PowerSoil DNA isolation kit (MO-BIO; Carlsbad, CA, United States of America) following 
the manufacturer’s instruction except for the elution step that was done in 60 µl purified 
water. Extracted samples were quantified on a Qubit 2.0 fluorimeter (Life Technologies; 
Darmstadt, Germany) using the dsDNA high-sensitivity assay. 
c. Sequencing and data analysis.  
DNA libraries were prepared from 30 µl of the different samples using NEBNext Ultra 
(New England Biolabs; Ipswich, MA, USA) library preparation kits. Samples were pooled 
on an Illumina HiSeq 2500 (Illumina; San Diego, CA, USA) in 2x125 base pairs (bp) 
paired-end mode for sequencing. An in-house developed Perl pipeline was used to 
automatize the dataset analysis in three steps, namely (i) a pre-processing step of the 
raw sequences datasets; (ii) an assembly of the curated datasets; and (iii) the comparison 
of the obtained sequences to various databases. 
 Pre-processing of the raw datasets was further divided into two sub-steps, 
including (i) a quality control; and (ii) a quality filtering of raw sequences. The tool FastQC 
(Andrews) in version 10.1 was used to assess the overall sequencing quality and the 
software suite EA-utils (Aronesty 2011) in its version 1.1.2 was used to remove the reads 
not passing the proprietary CASAVA filter from Illumina. The same tool suite was used to 
remove bases with a quality score below Q20 at both 5’ and 3’ ends. The assembly was 
performed using the MIRA assembler (Chevreux 2007) in its version 4.0.2 in de novo and 
accurate modes with four assembly passes for each sample (nop= 4). Computing-wise, 
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a high-performance cluster running under CentOS 6.5 was used and 24 computing cores 
and >512 gigabyte RAM were allocated to each assembly job. 
 The third step of the analysis was the comparison to two different databases, 
namely (i) the National Centre for Biotechnology Information nucleotide (NCBI nt) 
database (Benson et al 2013); and (ii) the genome-specific markers database (GSMer; 
(Tu et al 2014)). The comparison was performed using the BLAST software in its version 
2.2.28+ (Camacho et al 2009). The features of the comparative analyses against the two 
different databases are summarized in Table 1. The complete taxonomic information for 
each BLAST hit was retrieved using the NCBI taxon identifier (taxid) and the 
corresponding BioPerl (version 1.2.9; (Stajich et al 2002)) features. 
 
Database NCBI nt GSMer 
Sequence type Publicly available sequences 
Bacterial strain-specific 
markers 
Number of 
sequences 
182’188’746 > 2’000’000 
Organism 
spectrum 
Any sequenced organisms 5418 bacterial strains 
Sequence size (bp) N.A. 50 bp 
BLASTn 
parameters 
WS: 300 -> 150 -> 100 -> 50; 
EVC: 10^-5 
WS: 50; EVC: 10^-5 
Sequenced 
compared 
Assembled contigs Curated reads 
Information 
obtained 
Prevalence of non-bacterial 
pathogens with quantitative 
information 
Prevalence of bacterial 
strains with quantitative 
information 
Table 1. Databases used in the metagenomics approach. This table shows the databases 
that were used in the bioinformatics workflow and highlights their characteristics. bp = 
base pairs; WS = Word size; EVC = E-value cut-off. 
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4. Results 
a. Sequencing profiles.  
Measured DNA concentrations ranged from 1.77 ng/µl to 19.2 ng/µl in a volume of 60 µl 
for a total DNA minimum of 106.2 ng and up to a maximum of 1’152 ng per sample. A 
total of 1’240’255’828 reads were sequenced for the twenty-two samples with an average 
of 56’275’265 reads per sample. On average, 22% of the reads were assembled into 
approximately 292’000 contigs with a N50 size of 645 base pairs (bp). Out of these 
~300’000 contigs, approximately one quarter were contigs larger than 500 bp with a N50 
of 1’421 bp. When utilising BLAST analysis, an average 44 % of the assembled contigs 
in each sample had a hit in the NCBI database. With regard to the GSMer database, an 
average of 11’588 matching reads or markers were found for each sample. Detailed 
results are provided in Supplementary Table 1. 
b. Spatial relationships.  
Using the taxonomic profiles derived from the comparison of the datasets with the GSMer 
database, we performed a hierarchical analysis of all samples, as shown in Figure 2. 
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Figure 2. Sample-to-sample relationships. Panel A. Correlation-based hierarchical 
cluster analysis of water samples based on the relative abundance of bacterial strains. 
The tree is constructed using the group average method and a Pearson correlation matrix. 
The dendrogram shows the degree of similarity between the different samples (scale = 
1). The three clusters that were selected for the rest of the study are highlighted in orange 
colour (cluster 1), green colour (cluster 2) and blue colour (cluster 3). Panel B shows the 
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total number of observed strains, per sample. The average cluster diversity is shown in 
dashed lines. Panel C shows the Shannon diversity index, per sample. The average value 
of the Shannon diversity per cluster is shown in dashed lines. Panel D. Radial 
representation of the sample-to-sample correlations coloured by cluster. The thicker the 
connecting line, the stronger the correlation between the samples.  
All samples collected on Lake Victoria (L1-L4) cluster together in the most distant 
ramification, that we named cluster 3. The rest of the samples is separated in two distinct 
branches, namely, (i) the samples collected at the channel locations (C1-C5) together 
with samples collected at six wetland locations (W3, W6, W7, W8, W10 and W13); and 
(ii) the remaining six wetland samples (W1, W2, W4, W11 and W12) that we subsequently 
refer to as cluster 1 and 2, respectively. The average number of bacterial strains found in 
cluster 1 (n = 493.5) was significantly higher than the average number of strains found in 
cluster 2 (p-value = 4.3*10E-4) and cluster 3 (p-value = 0.003). In contrast, the difference 
between cluster 2 and 3 was not significant. Similarly, the mean Shannon diversity index 
(SDI), an indicator taking into account both abundance and evenness within a sample, 
was significantly lower in cluster 2 (p-value = 0.003) and cluster 3 (p-value = 2.2*10E-15) 
than in cluster 1. SDI of cluster 2 and 3 is also significantly different (p-value = 2.4*10E-
7). 
We further used the GSMer derived profiles compare the number of identified E. coli 
strains against the total amount of bacterial strains per sample, using a linear regression 
analysis as shown in Figure 3.  
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Figure 3. Linear regression analysis of E. coli strains (ECS) and the total number of 
observed strains (NOS). This regression shows the relation between the intra species 
diversity of Escherichia coli and the total diversity. (R2 = 0.958, p-value < 1E10-4). The 
total number of observed species can be estimated along the Nakivubo channel using the 
following equation: NOS = 62.2 + 7.94*ECS. 
 
To assess the effect of distance to channel on the bacterial composition, we 
performed a linear regression analysis to assess the relation between distance and 
taxonomic correlation throughout the Nakivubo channel (Supplementary 1A) as well as 
the relations between the distance to the channel and the composition of the wetland 
samples from cluster 1 (Supplementary 1B-1G). 
c. Specificities of the environmental clusters.  
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Using the Lefse pipeline, we screened the GSMer profiles for bacterial strains that were 
significantly different in relative abundance between the three enviromental clusters. The 
results of this analysis are shown in Figure 4.   
 
 
Figure 4. Cluster related-biomarkers. The cladogram shows the statistically significant 
differences (p-value < 0.01, LDA > 4.0) in abundance of bacterial taxa between the three 
environmental clusters. For clarity purpose, we show here only the significant differences, 
down to the taxonomical level of order. For complete list of identified organisms, see 
Supplementary Table 2. Members from the Archaea and Bacteria domains are shown 
here. FCB_group = Bacteroidetes/Chlorobi group. 
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          The bacterial composition of the clusters harbours various specificities. All results 
discussed in this section which involve taxonomic levels below “order” can be consulted 
in Supplemental Table 2. In brief, abundance differences include gram-positive bacteria 
from the Firmicutes and Actinobacteria phyla, which are over-abundant in samples from 
cluster 1. The differences in Clostridia abundance include species from the Blautia and 
Ruminococcus genera whereas differences in the Bacilli include species from the 
Enterococcus, Streptococcus and Exiguobacterium genera. Escherichia coli and 
Enhydrobacter aerosaccus are also over-represented in cluster 1. Over-abundance of 
Prevotella and Bacteroides genera, within the gram-negative Bacteroidetes phylum and 
of Methanosaeta concilii (Phylum Euryarcaeota) are additional characteristics of cluster 
1 samples. For cluster 2, we highlighted the overabundance of one phylum, namely the 
Proteobacteria. This overrepresentation includes members from the Alpha- 
(Novosphingobium spp.), Beta- (Comamonas testosteroni and Dechloromonas 
aromatica), Delta- (Geobacter spp.) and Gammaproteobacteria classes (Pseudomonas, 
Acinetobacter, Pasteurella and Aeromonas genera). Cluster 3 is characterized by the 
over-abundance of Cyanobacteria, with Microcystis aeruginosa being the main driver of 
this difference. 
d. Risks associated with wastewater contamination.  
To assess the potential risk caused by wastewater contamination on human health, we 
assessed the relative abundances of a set of known waterborne bacterial pathogens 
throughout the Nakivubo system, which we refer to as the “pathobiome” (Figure 5A). We 
expanded this analysis to eukaryotic parasites and viral pathogens (Figure 5B) that were 
identified from the comparison of de novo assembled contigs with the NCBI nt database. 
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Figure 5. Prevalence of important waterborne pathogens across the Nakivubo system. 
Panel A. Bar chart representing the cumulative abundance of bacterial pathogens at the 
different sampling locations. The line indicates the number of pathogenic classes for each 
sample. Panel B. Bar chart representing the cumulative abundances of parasitic, fungal 
and viral pathogens in the Nakivubo system. The line shows the number of pathogenic 
classes found at each sampling location. For clarity, samples are sorted per 
environmental cluster. 
In terms of diversity, the most diverse bacterial pathobiomes are found in samples 
C3, C4 and W3 with seven pathogenic classes (PC) followed by C1 and C5 (PC = 6) and 
samples collected at locations C2, W13, W10, W7 and W14 (PC = 5). The bacterial 
pathobiome represents more than 1% of the total bacteria in seven samples (C1, C4, C5, 
W8, W10, W14, W1) and close to 1% in samples C2 (0.97%) and C3 (0.90%). Using a 
Kruskal-Wallis test, we tested whether the abundance of these bacterial pathogens is 
significantly different between the environmental clusters and found that high abundance 
of agents causing salmonellosis, yersinosis and shigellosis is significantly associated with 
cluster 1 (p-value = 0.018, 0.036 and 0.008, respectively). 
Regarding the remaining organisms composing the pathobiome, including 
parasitic, viral and fungal pathogens, the most diverse pathobiome was found in L1 (PC 
= 9), followed by locations W4 and C2 with 8 pathogenic classes and C2, W4, L2 and L4 
with 7 pathogenic classes. The highest cumulative abundances of these pathogens were 
found in samples obtained from the wetlands (W4>W3>W2>W10>W6). Agents 
responsible for microsporidiosis were significantly more abundant in cluster 1 (p-value = 
0.003), while the mean relative abundance of Giardia intestinalis was higher in samples 
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collected in Lake Victoria (cluster 3). DNA traces of Cryptosporidium spp., Schistosoma 
spp. and Toxoplasma gondii were found homogeneously across all sampling locations 
with a prevalence of 95%, 95% and 81%, respectively. 
5. Discussion 
In this study, we used a metagenomics approach to perform an in-depth analysis of the 
microbial composition of water samples taken along a wastewater channel in Kampala, 
Uganda, in an attempt to characterize and elucidate associated health threats. To our 
knowledge, this is the first study to apply such an approach based on ultra-deep shotgun 
sequencing with subsequent strain-level characterization in a sub-Saharan African 
setting.  
Several findings obtained during this work are worth discussing. First, the 
correlation of the bacterial strain profiles showed a clustering of all samples into three 
different groups, with one group containing all samples from Lake Victoria, while another 
one was not only composed of all samples collected on the Nakivubo channel, but also 
of some of the samples collected directly on the surrounding wetlands. The third group 
represented the majority of wetland samples. The heterogeneous repartition of wetland 
samples in different clusters clearly indicates that contamination of wastewater from the 
Nakivubo channel occurs throughout the wetlands, which might have important 
implications for human health. As the sampling period was performed during a rain-free 
period, we strongly believe that this contamination cannot be explained by, e.g., 
temporary flooding, but rather by permanent leakage around the wastewater channel.  
Second, our results yield interesting patterns regarding the intra-species 
distribution of E. coli strains in the different clusters. Indeed, E. coli plating and counting 
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is used as the standard method to assess the faecal-related contamination of water, and 
it has been shown previously that the counts of total faecal coliforms and E. coli in the 
Nakivubo wastewater system are above the threshold recommended by WHO (means of 
2.9*105 and 9.9*104 colony forming units per 100mL, respectively (Fuhrimann et al 
2015)). Here, we showed that, in addition to such a quantification of E. coli colonies, the 
intra-species diversity of E. coli is also strongly correlated to the total bacterial diversity. 
The establishment of diversity thresholds based on e.g. the average cluster means of E. 
coli strains might be helpful to provide a better description of the microbiological diversity 
of a certain ecosystem and the arising health consequences. 
Third, sampling locations C1 and C2 are located upstream and downstream 
respectively of the Bugolobi sewage treatment facility which is located at the latitude of 
0.3182079° and longitude of 32.6070297°. The number of observed strains decreased 
from 899 to 745 between both samples while the Shannon diversity index decreased only 
slightly from 4.85 to 4.68 indicating a slight effect of the decontamination process on the 
microbial composition. Among this effect, we noticed the apparition of several bacterial 
genera related to the sludge treatment process, including but not limited to the 
Aminobacterium or Aminomonas genera (Baena et al 1998, Baena et al 1999) as well as 
several methanogens. It is worthwhile noticing that some bacterial genera including 
Erysipelothrix or Parasutterella that have been isolated from faecal material (Morotomi et 
al 2011, Wood 1974) are also introduced in the process hinting towards previous and 
potentially permanent contamination of the infrastructure. Shigellosis, salmonellosis, and 
yersinosis causing agents, among others, see their relative abundances decrease. 
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Finally, abundances of several bacteria including some genera commonly known 
to contain human pathogenic species are increasing between both locations. This specific 
aspect, although based on two samples, shows that the microbial treatment capacity or 
process of the Bugolobi sewage treatment facility is sub-optimal.  
To pinpoint the potential leakage points of the Nakivubo channel, we tested 
whether taxonomic correlation is a function of the distance between each sampling points, 
along the Nakivubo channel. We showed that distance explains more than 90% of the 
taxonomic correlation between all samples from the channel. We further compared these 
two metrics between individual wetland samples that grouped with the channel samples 
in environmental cluster 1. For four of the points, namely W6-8 and W10, we found a 
strong correlation between the bacterial composition and their closest sampling points on 
the wastewater channel. W6-8 are spatially closest to C4 while W10 is closest to C5. This 
enables us to hypothesize that containment of wastewater is insufficient around locations 
C4 and C5 on the Nakivubo channel and that leakage happen in the wetlands around 
these points. This approach, combined with additional sampling points to increase 
resolution could help us establish an exact map of the system’s weakness. 
After demonstrating that the Nakivubo channel clearly impacts its immediate 
surroundings, and where this effect is the strongest, we aimed at characterizing the exact 
compositional differences between the three environmental clusters. Samples from 
cluster 1 are characterized by an over-abundance of bacterial strains from the Firmicutes, 
FCB-group, Actinobacteria and Euryarchaeota phylum which are phylum commonly 
found in the human gastrointestinal tract (Eckburg et al 2005, Human Microbiome Project 
2012). Escherichia coli overabundance in samples from cluster 1 also hints towards the 
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same faecal origin. It is worthwhile to notice the overabundance of members from the 
Proteobacteria in cluster 2. This overabundance however doesn’t include any bacteria 
strictly related to the gut microbiota and mainly include known environmental bacteria 
(Shin et al 2015). Samples collected in the inner Murchison bay are characterized by the 
over-abundance of Microcystis aeruginosa, which is commonly found in freshwater and 
under warm temperatures, which correlate with the context of Lake Victoria.   
Fourth, when looking specifically at the bacterial pathobiome in the Nakivubo 
system, there is evidence that a high absolute diversity of pathogens, or number of 
pathogenic classes, is associated with the samples from cluster 1. There is also strong 
evidence that Salmonella enterica, Shigella spp. and Yersinia pestis contamination are 
directly related to wastewater, while other potential bacterial pathogens that we focused 
on aren’t. In the case of Mycobacterium spp. and Vibrio spp., the lack of cluster specificity 
is probably due to the ubiquitous aspect of these bacterial species (Primm et al 2004, 
Raszl et al 2016, Thompson et al 2004) and a more targeted screening of, e.g. virulence 
factors might result in a different picture. It is worthwhile noticing that Listeria 
monocytogenes is present in 4 samples from cluster 1 but that the very low relative 
abundance in three of these samples isn’t sufficient to statistically link the species with 
wastewater contamination. Legionellosis agent is present in a minority of samples from 
each cluster, indicating that the Nakivubo channel isn’t the source of it. The last 
observation we made is about the heterogeneous repartition of pathogenic E. coli strains 
which speaks in favour of past contamination events, as it is present in a vast majority of 
samples from cluster 1 as well as in some samples from cluster 2, in a relatively high 
abundance. This could also be interpreted as the natural treatment function of the 
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wetland, with pathogenic E. coli being the only bacteria in our study that isn’t naturally 
removed over time. 
Regarding parasitic, fungal and viral pathogens, the situation is different, as all but 
two species are not specifically related to wastewater contamination by the Nakivubo 
channel. Microsporidia, a fungal agent that is known as an emerging opportunistic 
pathogen (Curry and Smith 1998, Stentiford et al 2016) causing, among others, 
gastrointestinal-related symptoms, is found to be strongly linked to samples from cluster 
1, indicating a strong effect from the Nakivubo channel on this potentially important 
pathogen. While found in one sample of both clusters 1 and 2, a high relative abundance 
of Giardia intestinalis seems to be correlated with samples from cluster 3, ruling out the 
effect of wastewater contamination in this specific case. It is interesting to notice that three 
of the parasitic pathogens, namely Schistosoma spp., Toxoplasma gondii and 
Cryptosporidium spp. are found in over 80% of the samples, indicating that the Nakivubo 
system is potentially a strong source of contamination with these pathogens. 
To conclude this study, we showed that system-wide characterization is possible, using 
an ultra-deep metagenomics approach and state-of-the-art bioinformatics and that it 
yielded in-depth insights of a complex system such as the Nakivubo system. While the 
resolution of the study is limited by the number of sampling locations and by the lack of 
temporally distinct sampling, the sequencing depth of each samples already allowed us 
to highlight several specificities of the Nakivubo channel, wetlands and of the inner 
Murchison bay. In this specific setting, we are able to draw four main conclusions, namely, 
i) that the system harbours, based on the microbial composition, three distinct 
environmental groups, ii) that the Nakivubo channel has a clear impact on the wetland 
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microbiota in specific locations and that it’s containment potential isn’t sufficient, iii) that 
leakage of wastewater occurs around two sampling locations, in dry periods and iv) that 
several potentially harmful microorganisms for human health are found to be spread by 
wastewater contamination. 
6. Conclusions 
• The bacterial composition in the wetlands is very heterogeneous with some 
hotspots of contamination, which indicates that some wetland areas may pose a 
significant health threat to humans. 
• Intra-species diversity of Escherichia coli is proportional to the total number of 
observed strains. An E. coli diversity assay could be used to estimate the 
contamination status of the wetland with a lower cost and denser resolution. 
• Contamination with several human pathogens around the system is associated 
with wastewater. Leakage points indicate that the containment potential of the 
Nakivubo channel is sub-optimal and poses a threat to human health. 
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Chapter VI. Discussion and perspectives 
1. Impact of NGS on the field of infectious diseases research 
Next-generation sequencing, due to its naïve and relatively unbiased nature, 
revolutionized how studies in the field of infectious diseases are conducted. Major 
examples of how these new approaches influenced the field of infectious diseases 
include, but are not limited to; (i) the unravelling of new insights into the microbial genetic 
diversity (Cirulli and Goldstein 2010, Prosperi et al 2011); (ii) the discovery of new 
pathogenic microorganisms previously unknown (Mardis 2009, Palacios et al 2008); and 
(iii) highlighting worsened symptomatic expression of diseases caused by coinfection 
events as well as gaining insights into dynamics of microbiomes or other complex 
microbial communities (Cho and Blaser 2012, David et al 2014, Koenig et al 2011, 
Salipante et al 2014). This PhD thesis sought to apply these techniques within several 
complex situations, extending their application beyond the established frontier, and 
further developing the optimized usage of these types of studies. 
a. A bioinformatics tool to improve accuracy and specificity of molecular assays 
The first part of this thesis was aimed at developing a bioinformatics workflow that would 
adapt to the challenge caused by the tremendous amount of nucleotide sequences made 
available since NGS was brought on the market. In fact, while increased amounts of 
sequences have offered decisive insights in research on infectious diseases 
(Capobianchi et al 2013, Radford et al 2012), they are also accompanied with challenges, 
one of them being the lack of bioinformatics approaches able to process such datasets. 
We developed a bioinformatics workflow that allowed the selection of highly conserved 
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and specific molecular markers, and we validated it by testing different types of molecular 
assays, including real-time PCR, LAMP and Sanger sequencing assays, using the 
selected markers. The study focused on thirteen neglected viral pathogens from the 
Flaviviridae and Bunyaviridae families that pose a serious threat to human health and 
were responsible for several outbreaks (Aradaib et al 2011, Balogh et al 2010, Lanciotti 
et al 1999, Lvov et al 2000, Spinsanti et al 2008, Woods et al 2002). This approach, based 
on the widely available BLAST algorithm enabled the selection of these markers among 
several hundreds of complete genomic sequences for the most extensively sequenced 
viral species used in this study. This study confirms the usefulness of this tremendous 
amount of sequencing data, provided suitable analysis workflows are available, to 
improve accuracy and specificity of molecular diagnostics. 
b. Identification of a new virus from a complex plant microbiome 
The second part of this thesis was focusing on the discovery and molecular 
characterisation of the microbial organism causing leafroll symptoms in a Vitis vinifera cv. 
Otcha bala plant. This example showed how a metagenomics approach could 
successfully complement standard diagnostic tools. In this case, a preliminary analysis 
using electron microscopy allowed the determination of the origin of the causative agent, 
which was in fact an unidentifiable virus. Leafroll disease in grapevine has a complex 
aetiology since various viral species were usually associated with this disease. The viral 
metagenome present in this sample could be completely characterised using 454 
sequencing and an in-house developed bioinformatics pipeline.  Complete or partial 
genomes from four viral species could be reconstructed, namely (i) the Grapevine fleck 
virus and the Grapevine red globe virus that are both members of the Tymoviridae family, 
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(ii) the Grapevine virus A from the Betaflexviridae family; and (iii) a thirteen Kb long contig 
closely related to Closteroviridae, that we proposed to name Grapevine leafroll-
associated virus 4 strain Ob (GLRaV-4 Ob). Since none of the three first viruses were 
known to cause symptoms in Grapevine, and with the confirmation obtained by additional 
serological tests, we were able to demonstrate that this new viral variant was in fact the 
causative agent of the Grapevine disease. This study confirmed, that omics approaches 
are useful to determine aetiology of a disease that could not be identified and/or fully 
characterised with other tools. 
c. Metagenomics and its application in personalized medicine 
Microbiome characterisation is a powerful tool and one pillar of the rapidly growing field 
of personalized medicine (Collins 2010, Isaacs and Ferraccioli 2011, Nicholson et al 
2005, Nicholson 2006, Tsai and Coyle 2009). The third part of this thesis focused on 
assessing the potential of a metagenomics approach for the characterisation of the gut 
pathobiome (microbiome restricted to pathogenic microorganisms) and for the generation 
of additional individual health-related information. In this proof-of-concept study, stool 
samples from four patients presenting persistent digestive disorders were screened for a 
wide range of pathogenic microorganisms. We were able to demonstrate the consistency 
of this approach for the diagnosis of pathogens associated with this digestive syndrome 
by comparing it with a set of validated diagnostic approaches, including microscopy, rapid 
diagnostics tests and multiplex PCR assays. The detection rate of bacterial pathogens 
and helminths was in favour of the metagenomics approach, which permitted the 
identification of a wider range of species belonging to these pathogenic classes, including 
Mycobacterium spp. and Schistosoma mansoni. However, for viruses and intestinal 
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protozoa, the detection rate was more in favour of the standard tools, mainly for two 
reasons, namely, (i) because the sequencing depth was not sufficient to detect viral 
sequencing reads in this complex sample; and (ii) because there is a lack of sequence 
data for protozoan species. These two issues are only temporary, since sequencing 
technologies are permanently improved and are expected to provide a higher sequencing 
depth making even the rarest organisms clearly identifiable. Also, current protozoa 
sequencing projects will provide additional sequence data for these species, closing up 
the sequencing gap between these and other microorganisms for which more complete 
genomic sequences are available, like helminths (Berriman et al 2009, Park et al 2011, 
Young et al 2012, Zhou et al 2009). In addition to the confirmation of the diagnostic 
potential of this metagenomics approach, we also generated additional health-related 
information by screening the sequence datasets for antimicrobial resistance genes. While 
this approach has several limitations, mainly bioinformatics-wise due to the diversity of 
mechanisms involved in antibiotics resistance in bacteria, it provides important 
information about the resistome and potential resistances that are present or could quickly 
spread in an environment as complex as the human gut microbiome. 
d. Wastewater microbiota and its impact on human health 
The final part of this PhD thesis was to apply a metagenomics approach to enable a 
system-wide microbial survey and to assess the potential risk on human health. In this 
study, we were able to conduct a complete survey of microbial communities present in 
the wastewater network from the city of Kampala, Uganda. We demonstrated how closely 
the diversity of E. coli, which is a standard indicator of faecal contamination recommended 
by the WHO, was linked to the overall diversity of bacteria in different aquatic ecosystems. 
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This is an important result for future studies that could then specifically concentrate on 
analysing the diversity of E. coli in order to assess the impact of human activity on the 
bacterial communities in the surrounding environment. Analysing the overall bacterial 
diversity confirmed the pertinence of our three environmental groups, by clearly 
generating three distinct sample clusters. Using assembled sequences from the 22 
metagenomics datasets also allowed us to characterise the geographical repartition of 
the different pathogenic classes among the Nakivubo wetland. Similarly, we were also 
able to summarise the main waterborne pathogens causing symptoms in humans and 
how they spread through this ecosystem using this metagenomics approach.  
In addition to this environmental assessment, this project included a second part 
with the aim of investigating the impact of wastewater exposure on the human gut 
microbiome. For this purpose, 114 stool samples were collected from different population 
groups around Kampala. We selected three population groups that we expected to be at 
different level of exposure to wastewater from the Nakivubo channel and wetlands. This 
included 38 samples (S001-S038) from what we described as the high exposure group. 
The individuals in this group were directly exposed to water contact on a daily basis due 
to their farming activities in the Nakivubo wetlands. Sample S039 to sample S078 were 
collected from individuals living in the slum areas surrounding the Nakivubo swamps, at 
occasional risk of exposure to wastewater, mainly because of occasional flooding events. 
The last group, including samples S079 to S114 originated from a control population, 
rarely or never coming into contact with the water from the Nakivubo channel/wetlands. 
A first result of the ongoing analyses is shown in Figure 1 where we were able to show 
how the bacterial composition of the environmental samples impacted the gut bacterial 
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microbiomes of the surrounding populations. With this analysis, we were able to 
demonstrate that substantial differences in the bacterial communities exist between the 
three population groups from this study. In fact, 15 out of 18 stool samples clustering 
together with the environmental samples were from Group 1 suggesting that the gut 
microbiomes of this group, in which individuals are exposed to water on a daily basis, are 
deeply impacted by their exposure to wastewater. This is only a snapshot of this study 
and we hope that the aggregation of these data with the answers collected using health 
questionnaires will bring further insights in the impact of wastewater management in 
Kampala on human health. 
 
Figure 1. Hierarchical 
clustering of the bacterial 
communities from both 
environmental and 
human samples. A blue 
gradient indicates the 
number of markers found 
for each bacterial strain. 
The lighter the shade, 
the more markers were 
found. 
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2. Future of omics approaches and associated challenges 
a. The future of NGS 
Next-generation sequencing is rapidly pervading all areas of infectious diseases: 
improving speed, precision, and, last but not least, the breadth of diagnostics. This 
statement is even truer since sequencing technologies are constantly evolving and 
becoming more straightforward and easy to apply to different projects. The field of single 
molecule sequencing through a nanopore is one of the area of NGS which holds most 
promises and interesting applications (Bayley 2015, Feng et al 2015, Garaj 2014, Jones 
2015). Recently, a number of studies involving nanopore sequencing have shown that 
the technology, while it has yet to be optimized, already shows great potential (Kilianski 
et al 2015, Loman and Watson 2015). It is predicted that the omics applications of NGS 
presented in this thesis will be greatly improved by the use of these new nanopore 
sequencing technologies. For instance, studies show early promising results in the 
screening of antimicrobial resistance genes using this technology (Ashton et al 2014, 
Judge et al 2015) 
The other great improvement lies in the miniaturisation of the sequencing devices. 
Until now, NGS instruments could only be used in an equipped laboratory and some, like 
the Pacific Biosciences RSII instrument, even required a specific room due to its massive 
size. The nanopore sequencing instrument from Oxford Nanopore, the MinION, has the 
size of an usb stick and protocols are currently being optimized to allow the direct deposit 
of a sample without pre-purification steps. This improvement will allow to bring this 
handheld device directly to the patient as a point-of-care diagnostics device, allowing 
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cheaper, faster yet more accurate results on-site. In a closer future, we can expect that 
the technical characteristics of current NGS technologies will be continuously improved. 
Current applications, like metagenomics or metatranscriptomics will greatly benefit from 
increased sequencing read-length and deeper coverage for a lower price. 
b. Associated bioinformatics challenges 
Besides many insights, the expected data deluge also brings questions, especially in the 
area of bioinformatics. This includes challenges with handling, processing and moving 
information, challenges that were historically reserved for astronomers and high-energy 
physicists (Marx 2013). Biologists now have to store, analyse, compare and share 
massive amount of sequencing data – which is not a simple task when a single sequenced 
human genome is already 140 gigabytes in size (Marx 2013, Stephens et al 2015). 
Increased computing resources, including additional and faster storage, as well as 
additional computing cores are nowadays a requirement for any laboratory wanting to 
embark in the omics field. There is also a need to find consensuses on the software side, 
with the need of standardised bioinformatics workflows for applications involving NGS. All 
in all, bioinformatics should, with specific educational programs for future scientists, now 
benefit from the same attention and development pace as NGS technologies. 
 
 
3. General conclusion 
Omics approaches, facilitated by the advancements of NGS technologies, have 
revolutionised the way research is conducted in the field of infectious diseases. Many 
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challenges that were mainly due to the vast diversity of pathogenic microorganisms can 
now be approached differently. There are many examples of applications improving 
research in infectious diseases. This includes the field of genomics, which by multiplying 
the number of sequenced genomes by a factor of over 1000 between the years 2000 and 
2015 (Stephens et al 2015), permitted further insights in the genetic diversity of many 
pathogens. Meta-analyses, like metagenomics or metatranscriptomics are the 
applications that benefited most from the use of NGS technologies, and they now allow 
system-wide studies, where previous studies were only focusing on one parameter (one 
microbe or one specific gene for instance). However, these omics approaches have their 
limitations, mainly due to the bioinformatics challenges they give rise to. In conclusion, it 
is foreseeable that these approaches, once matured, due to the increased amount of 
results they allow to generate, will be widely used and will replace standard approaches 
in the field of infectious diseases. 
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